https://www.moreblossom.com/trials/effect-of-a-single-low-dose-dose-of-esketamine-on-postpartum-depression-and-quality-of-recovery 2026-05-11T20:28:17Z monthly 0.7 https://www.moreblossom.com/trials/an-open-label-study-to-evaluate-the-safety-tolerability-and-pharmacodynamics-of-bpl-003-in 2026-05-07T16:12:51Z monthly 0.7 https://www.moreblossom.com/trials/acute-and-delayed-effects-of-mdma-intoxication-on-false-memories-in-a-legal-context 2026-03-17T13:35:46Z monthly 0.7 https://www.moreblossom.com/trials/eskale-descriptive-study-of-patients-with-treatment-resistant-depression-treated-with-esketamine 2026-04-16T13:05:42Z monthly 0.7 https://www.moreblossom.com/trials/clinical-studies-of-lysergic-acid-diethylamide 2026-04-13T09:47:01Z monthly 0.7 https://www.moreblossom.com/trials/usp-2021-ayahuasca-sad-rct-pilot 2026-04-20T17:39:09Z monthly 0.7 https://www.moreblossom.com/trials/freedman-1962-archpsyc-lsd-autistic-children 2026-04-20T18:19:21Z monthly 0.7 https://www.moreblossom.com/trials/manson-2023-jpd-ketamine-indigenous-rtt 2026-04-20T18:33:57Z monthly 0.7 https://www.moreblossom.com/trials/glue-2017-jpp-ketamine-anxiety-anzctr 2026-04-16T13:17:35Z monthly 0.7 https://www.moreblossom.com/trials/krupitsky-2002-jsat-ketamine-heroin-russia 2026-05-11T20:50:25Z monthly 0.7 https://www.moreblossom.com/trials/umin000032355-ketamine-esketamine-brazil-ufba 2026-04-16T13:23:37Z monthly 0.7 https://www.moreblossom.com/trials/wu-2023-jad-ketamine-pain-social-mdd-china 2026-04-20T18:28:36Z monthly 0.7 https://www.moreblossom.com/trials/galvez-2018-jpsychopharm-intranasal-ketamine-trd-pilot 2026-04-20T18:03:07Z monthly 0.7 https://www.moreblossom.com/trials/alipoor-2021-jmedlife-ketamine-postpartum-iran 2026-05-12T13:57:21Z monthly 0.7 https://www.moreblossom.com/trials/bouso-2008-jpsychoactivedrugs-mdma-ptsd-madrid 2026-04-20T17:10:08Z monthly 0.7 https://www.moreblossom.com/trials/psyrreal-vr-psychedelic-replication-feasibility-study-estonia-2021 2026-04-20T18:32:11Z monthly 0.7 https://www.moreblossom.com/trials/propofol-enhanced-assessment-of-ketamine-for-chronic-pain-and-depression-peak 2026-05-14T20:14:19Z monthly 0.7 https://www.moreblossom.com/trials/a-clinical-study-of-lsd-treatment-in-alcoholism 2026-05-14T20:14:19Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-psychotherapy-in-the-treatment-of-trauma 2026-04-14T09:03:05Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-glutamatergic-modulation-on-cocaine-self-administration 2026-05-07T16:07:02Z monthly 0.7 https://www.moreblossom.com/trials/anzctr-12618001042235-bedroc-r107-extended-release-ketamine-trd 2026-05-12T11:03:19Z monthly 0.7 https://www.moreblossom.com/trials/umin000033760-low-dose-ketamine-acute-maintenance-depression-suicide 2026-04-14T19:27:41Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-brief-potent-glutamatergic-modulation-on-disordered-alcohol-use 2026-05-12T12:18:24Z monthly 0.7 https://www.moreblossom.com/trials/understanding-the-glutamate-system-in-adults-with-obsessive-compulsive-disorder-with-n-methyl-d 2026-05-07T16:05:16Z monthly 0.7 https://www.moreblossom.com/trials/moreno-2006-psilocybin-ocd-phase-i-dose-escalation 2026-05-12T16:24:07Z monthly 0.7 https://www.moreblossom.com/trials/nct02766192-timber-ketamine-mbct-ptsd 2026-05-11T22:22:02Z monthly 0.7 https://www.moreblossom.com/trials/inhaled-nitrous-oxide-for-treatment-resistant-depression-optimizing-dosing-strategies 2026-05-07T16:07:48Z monthly 0.7 https://www.moreblossom.com/trials/chictr2000041232-esketamine-adolescent-mdd-suicidal-ideation 2026-05-11T19:08:46Z monthly 0.7 https://www.moreblossom.com/trials/chictr-ipr-15007159-low-dose-ketamine-postpartum-depression-prevention 2026-05-11T22:27:03Z monthly 0.7 https://www.moreblossom.com/trials/anzctr-12613001064796-ascending-dose-noribogaine-opioid-dependent 2026-05-07T18:36:30Z monthly 0.7 https://www.moreblossom.com/trials/rbr-5rz5ch-nitrous-oxide-adjunctive-mdd 2026-04-16T13:23:59Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-brief-potent-glutamatergic-modulation-on-cocaine-dependence 2026-05-12T12:09:48Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-infusion-for-social-anxiety-disorder 2026-05-12T08:07:45Z monthly 0.7 https://www.moreblossom.com/trials/drozdz-2022-sublingual-ketamine-telehealth-retrospective 2026-04-20T18:36:08Z monthly 0.7 https://www.moreblossom.com/trials/noller-2018-ibogaine-oud-retrospective 2026-04-20T18:00:07Z monthly 0.7 https://www.moreblossom.com/trials/kast-1967-pq-lsd-terminal-cancer 2026-04-20T18:17:29Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-treatment-for-ptsd-nct02397889-mount-sinai 2026-05-07T16:06:39Z monthly 0.7 https://www.moreblossom.com/trials/irct201508201556n80-ketamine-vs-diclofenac-depression-chronic-headache 2026-05-11T22:12:50Z monthly 0.7 https://www.moreblossom.com/trials/gent-2024-jpp-esketamine-aud-exeter 2026-05-11T19:57:17Z monthly 0.7 https://www.moreblossom.com/trials/xiao-2023-jama-esketamine-mdd-beijing 2026-05-11T18:40:02Z monthly 0.7 https://www.moreblossom.com/trials/ross-2019-acp-ketamine-ptsd-veterans 2026-04-20T17:50:15Z monthly 0.7 https://www.moreblossom.com/trials/zheng-2019-jpp-ketamine-mdd-guangzhou 2026-05-12T11:48:55Z monthly 0.7 https://www.moreblossom.com/trials/nct03896256-ketamine-refractory-chronic-migraine 2026-05-12T14:48:25Z monthly 0.7 https://www.moreblossom.com/trials/kotoula-2022-bpsc-ketamine-reward-remission 2026-04-20T18:05:11Z monthly 0.7 https://www.moreblossom.com/trials/wild-health-2024-biorxiv-ketamine-epigenetics-mdd-ptsd 2026-04-20T17:57:43Z monthly 0.7 https://www.moreblossom.com/trials/nct02727998-ptsd-ketamine-exposure-yale 2026-05-07T16:07:10Z monthly 0.7 https://www.moreblossom.com/trials/veraart-2025-jpsychopharm-oral-esketamine-trd-nl 2026-05-11T19:39:04Z monthly 0.7 https://www.moreblossom.com/trials/rybakowski-2014-pharmacopsychiatry-ketamine-bipolar-poland 2026-05-11T21:28:52Z monthly 0.7 https://www.moreblossom.com/trials/umin000016985-ketamine-trd-tvgh-taiwan 2026-05-11T21:40:49Z monthly 0.7 https://www.moreblossom.com/trials/krupitsky-2007-jpsychoactivedrugs-kpt-heroin-russia 2026-05-11T21:03:07Z monthly 0.7 https://www.moreblossom.com/trials/spring-grove-1965-1972-lsd-dpt-terminal-cancer-program 2026-04-20T18:44:25Z monthly 0.7 https://www.moreblossom.com/trials/tomsovic-1970-qjstudialcohol-lysergide-alcoholics 2026-04-20T18:42:25Z monthly 0.7 https://www.moreblossom.com/trials/greer-1986-jpsychoactivedrugs-mdma-clinical-series 2026-04-20T18:25:50Z monthly 0.7 https://www.moreblossom.com/trials/irrmischer-2025-psychopharmacol-psilocybin-naturalistic-nl 2026-05-13T03:45:31Z monthly 0.7 https://www.moreblossom.com/trials/cap-ketamine-for-antidepressant-resistant-ptsd 2026-05-11T23:00:42Z monthly 0.7 https://www.moreblossom.com/trials/chictr2300068591-esketamine-smoking-cessation-lung-cancer-mdd 2026-05-11T20:14:08Z monthly 0.7 https://www.moreblossom.com/trials/umin000033916-low-dose-ketamine-vs-midazolam-depression-suicide 2026-05-12T06:57:07Z monthly 0.7 https://www.moreblossom.com/trials/ntr1343-s-ketamine-fibromyalgia-pkpd 2026-04-16T13:07:45Z monthly 0.7 https://www.moreblossom.com/trials/lerner-2003-clonazepam-hppd-open-label 2026-04-20T17:45:09Z monthly 0.7 https://www.moreblossom.com/trials/sanches-2016-ayahuasca-spect-open-label 2026-04-20T17:38:04Z monthly 0.7 https://www.moreblossom.com/trials/berman-2000-ketamine-mdd-rct-yale 2026-05-11T20:42:06Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-acute-ketamine-administration-on-mental-representations-of-the-body-in-healthy-partic 2026-05-07T18:39:38Z monthly 0.7 https://www.moreblossom.com/trials/a-single-dose-safety-and-tolerability-study-of-oral-noribogaine-in-healthy-volunteers-a-single-c 2026-05-07T18:34:36Z monthly 0.7 https://www.moreblossom.com/trials/evaluation-of-instruments-and-procedures-used-to-measure-opioid-withdrawal-in-opioid-dependent-p 2026-05-07T18:40:04Z monthly 0.7 https://www.moreblossom.com/trials/cyp2d6-and-the-pharmacokinetics-of-ibogaine 2026-05-07T19:00:38Z monthly 0.7 https://www.moreblossom.com/trials/noribogaine-therapy-for-relief-of-opioid-withdrawal-phase-1b-a-phase-1b-single-center-randomized 2026-05-07T18:36:23Z monthly 0.7 https://www.moreblossom.com/trials/intranasal-dexmedetomidine-versus-intranasal-ketamine-for-prevention-of-emergence-agitation-afte 2026-05-07T19:01:00Z monthly 0.7 https://www.moreblossom.com/trials/perioperative-ketamine-to-reduce-postoperative-delirium-and-depression-in-elderly-patients-under 2026-05-07T18:40:13Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-low-dose-ketamine-on-postoperative-cognitive-dysfunction-in-geriatric-patients-undergo 2026-05-07T18:34:40Z monthly 0.7 https://www.moreblossom.com/trials/the-use-of-simultaneous-eeg-and-fmri-to-monitor-the-effects-of-ketamine-and-midazolam-on-brain-a 2026-05-07T19:00:49Z monthly 0.7 https://www.moreblossom.com/trials/a-single-centre-double-blind-randomised-parallel-group-ascending-single-and-multiple-dose-safety 2026-05-07T19:01:03Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-three-stepwise-doses-of-intravenously-administered-ketamine-infusions-on-cognitive 2026-05-07T18:36:39Z monthly 0.7 https://www.moreblossom.com/trials/single-dose-ketamine-pharmacokinetic-pharmacodynamic-relationships-in-healthy-volunteers 2026-05-07T18:40:50Z monthly 0.7 https://www.moreblossom.com/trials/evaluation-of-brain-glutamatergic-mechanisms-in-patients-with-treatment-resistant-anxiety-compar 2026-05-07T18:34:44Z monthly 0.7 https://www.moreblossom.com/trials/a-single-dose-randomised-2-period-2-sequence-crossover-comparative-bioavailability-study-between 2026-05-07T19:01:37Z monthly 0.7 https://www.moreblossom.com/trials/a-single-dose-randomised-2-period-2-sequence-crossover-comparative-bioavailability-study-between 2026-05-07T18:36:46Z monthly 0.7 https://www.moreblossom.com/trials/a-single-centre-double-blind-randomised-parallel-group-single-dose-signal-study-of-r-107-in-part 2026-05-07T18:36:48Z monthly 0.7 https://www.moreblossom.com/trials/pilot-study-on-the-effects-of-ketamine-on-mood-and-eating-disorder-cognitions-in-enduring-anorex 2026-05-07T18:36:51Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-therapy-for-internalizing-disorders-is-there-a-single-mechanism 2026-05-12T15:55:59Z monthly 0.7 https://www.moreblossom.com/trials/pilot-study-of-ketamine-in-phobic-participants-using-virtual-reality-stimuli 2026-05-07T19:02:33Z monthly 0.7 https://www.moreblossom.com/trials/replication-study-of-ketamine-in-phobic-participants-using-virtual-reality-stimuli 2026-05-07T18:42:08Z monthly 0.7 https://www.moreblossom.com/trials/active-controlled-trial-of-a-ketamine-assisted-group-mindfulness-intervention-for-alcohol-use-di 2026-05-07T18:37:16Z monthly 0.7 https://www.moreblossom.com/trials/brain-activity-effects-of-psychedelic-medicines-in-healthy-volunteers 2026-05-07T18:37:19Z monthly 0.7 https://www.moreblossom.com/trials/a-pilot-study-to-test-the-effects-of-a-single-microdose-of-ayahuasca-alkaloids-on-blood-patholog 2026-05-07T18:34:54Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-1-single-centre-randomised-double-blind-placebo-controlled-single-ascending-dose-study-t 2026-05-07T18:34:53Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-versus-ketamine-plus-behavioural-activation-therapy-for-adults-with-treatment-resistant 2026-05-07T18:34:54Z monthly 0.7 https://www.moreblossom.com/trials/feasibility-study-of-the-effect-of-psilocybin-in-response-to-brief-psychological-input-with-psyc 2026-05-07T18:34:57Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-efficacy-of-mdma-assisted-therapy-for-post-traumatic-stress-disorder-in-military-vete 2026-05-07T18:45:53Z monthly 0.7 https://www.moreblossom.com/trials/toward-embodied-healing-feasibility-of-a-psilocybin-assisted-psychotherapy-for-women-with-partia 2026-05-07T18:37:38Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-2b-double-blind-randomized-low-dose-comparator-controlled-clinical-trial-to-assess-the-e 2026-05-07T19:04:33Z monthly 0.7 https://www.moreblossom.com/trials/a-randomised-controlled-trial-to-investigate-the-effect-of-a-six-week-intensified-pharmacologica 2026-05-07T19:06:12Z monthly 0.7 https://www.moreblossom.com/trials/a-determination-of-the-safety-and-efficacy-of-psilocybin-assisted-psychotherapy-for-patients-wit 2026-05-07T18:37:53Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-1-open-label-pilot-study-to-assess-the-safety-feasibility-and-initial-efficacy-of-iv-inf 2026-05-07T18:35:00Z monthly 0.7 https://www.moreblossom.com/trials/feasibility-of-oral-ketamine-for-bipolar-depression-a-20-week-open-label-study 2026-05-07T18:44:51Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-1-open-label-single-cohort-study-to-evaluate-the-safety-and-pharmacokinetics-pk-of-a-sin 2026-05-07T18:35:01Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-plus-exposure-therapy-for-post-traumatic-stress-disorder-ptsd-open-label-pilot-study-ta 2026-05-07T18:35:02Z monthly 0.7 https://www.moreblossom.com/trials/neural-mechanisms-of-ketamine-antidepressant-treatment-20-exploring-how-ketamine-affects-the-bra 2026-05-07T18:35:05Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-1-open-label-single-arm-basket-trial-of-the-intravenously-administered-psilocin-trp-8803 2026-05-07T18:45:26Z monthly 0.7 https://www.moreblossom.com/trials/a-randomised-open-label-crossover-study-to-investigate-the-safety-tolerability-pharmacokinetics- 2026-05-07T18:35:03Z monthly 0.7 https://www.moreblossom.com/trials/an-open-label-trial-to-test-menstrual-cycle-effects-and-tolerance-to-low-dose-psilocybin-in-heal 2026-05-07T18:35:04Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-effects-on-non-prescribed-opioid-use-and-brain-and-cognitive-health- 2026-05-07T18:35:06Z monthly 0.7 https://www.moreblossom.com/trials/intra-operative-sedation-with-s-ketamine-to-improve-depression-in-patients-with-mental-depressio 2026-05-07T18:36:19Z monthly 0.7 https://www.moreblossom.com/trials/jesus-nunes-2022-hp-ketamine-trd-brazil 2026-04-20T18:34:56Z monthly 0.7 https://www.moreblossom.com/trials/kheirabadi-2020-jcp-ketamine-ect-mdd 2026-04-20T17:55:59Z monthly 0.7 https://www.moreblossom.com/trials/su-2017-npp-ketamine-trd-taiwan 2026-05-11T22:45:07Z monthly 0.7 https://www.moreblossom.com/trials/grof-1973-ipp-dpt-alcohol-spring-grove 2026-04-20T17:46:18Z monthly 0.7 https://www.moreblossom.com/trials/rodrigues-2024-jcp-ayahuasca-aud-brazil 2026-04-20T18:39:23Z monthly 0.7 https://www.moreblossom.com/trials/umin000038347-arketamine-trd-brazil 2026-05-12T09:41:00Z monthly 0.7 https://www.moreblossom.com/trials/cullen-2018-jcap-ketamine-adolescents-mdd 2026-05-12T11:33:28Z monthly 0.7 https://www.moreblossom.com/trials/batievsky-2023-frontpain-kap-chronic-pain 2026-05-12T10:57:05Z monthly 0.7 https://www.moreblossom.com/trials/zhang-2020-psychres-ketamine-ect-tianjin 2026-04-20T17:56:53Z monthly 0.7 https://www.moreblossom.com/trials/abdallah-2017-npp-ketamine-gbc-mdd-yale 2026-05-11T22:04:16Z monthly 0.7 https://www.moreblossom.com/trials/zhong-2016-jad-ketamine-ect-china 2026-05-12T13:46:29Z monthly 0.7 https://www.moreblossom.com/trials/colla-2024-jpsychres-ket01-oral-pr-ketamine-swiss 2026-05-12T15:28:33Z monthly 0.7 https://www.moreblossom.com/trials/horacek-novak-2010-2015-clinneuro-ketamine-mdd-czech 2026-05-12T14:41:21Z monthly 0.7 https://www.moreblossom.com/trials/su-2023-jad-ketamine-dlpfc-trd-suicidal-taiwan 2026-04-20T18:41:25Z monthly 0.7 https://www.moreblossom.com/trials/dakwar-2014-drugalcdep-ketamine-cocaine-crossover-nyspi 2026-04-20T18:08:01Z monthly 0.7 https://www.moreblossom.com/trials/carhart-harris-2016-lancetpsych-psilocybin-trd-imperial 2026-05-13T05:46:40Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-antidepressant-trd-china-chictr-ooc-17012239 2026-05-12T11:42:14Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-assess-the-use-of-methylone-in-the-treatment-of-ptsd-impact-1 2026-04-20T17:31:14Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-esketamine-on-inflammatory-mediators-postoperative-depression-like-mood-and 2026-04-01T20:52:23Z monthly 0.7 https://www.moreblossom.com/trials/the-efficacy-safety-and-mechanism-of-esketamine-vs-electroconvulsive-therapy-in-the-treatment-of 2026-04-01T20:52:28Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-s-ketamine-on-depression-inflammation-and-brain-mri-after-abdominal-surgery-in 2026-04-01T20:52:17Z monthly 0.7 https://www.moreblossom.com/trials/investigating-the-efficacy-and-pharmacokinetic-profiles-of-esketamine-at-various-doses-for 2026-04-01T20:52:30Z monthly 0.7 https://www.moreblossom.com/trials/controlled-study-of-esketamine-treatment-for-depression-with-suicidal-ideation-based-on-near 2026-04-01T20:52:31Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-different-doses-of-esketamine-on-postoperative-delirium-and-postoperative-cognitive 2026-04-01T20:52:34Z monthly 0.7 https://www.moreblossom.com/trials/a-study-on-the-rapid-antisuicidal-mechanism-and-therapeutic-efficacy-prediction-of-ketamine 2026-04-01T20:52:20Z monthly 0.7 https://www.moreblossom.com/trials/effect-and-mechanism-of-low-dose-esketamine-on-postoperative-cognitive-function-in-elderly-non 2026-04-01T20:52:36Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-esketamine-on-cognitive-behavioral-therapy-for-insomnia-adherence-in-patients-with 2026-04-01T20:52:38Z monthly 0.7 https://www.moreblossom.com/trials/observation-on-the-effect-of-low-dose-esketamine-combined-with-propofol-on-depressive-mood-in 2026-04-01T20:52:25Z monthly 0.7 https://www.moreblossom.com/trials/effectiveness-and-safety-of-dexmedetomidine-and-esketamine-combined-infusion-on-difficult-to 2026-04-01T20:52:40Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-sub-anesthetic-dose-of-esketamine-on-the-incidence-of-postoperative-anxiety-and 2026-04-01T20:52:43Z monthly 0.7 https://www.moreblossom.com/trials/trial-ctri-2026-04-109150 2026-05-15T10:54:10Z monthly 0.7 https://www.moreblossom.com/trials/psychotherapy-for-ketamines-enhanced-durability-in-chronic-neuropathic-pain-a-randomized-controlled-pilot-trial 2026-05-07T16:12:48Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-3-trial-of-mm120-for-generalized-anxiety-disorder-voyage 2026-05-14T20:14:19Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-3-trial-of-mm120-for-generalized-anxiety-disorder-panorama 2026-05-14T20:14:20Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-add-on-therapy-for-established-status-epilepticus-treatment-trial-kesett 2026-05-14T20:14:20Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-for-the-treatment-of-major-depressive-disorder-in-patients-with-non-small-cell-lung-cancer 2026-05-14T20:14:20Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-intervention-for-veterans-overcoming-treatment-resistant-depression 2026-05-14T20:14:20Z monthly 0.7 https://www.moreblossom.com/trials/mapping-ibogaine-neural-dynamics-in-opioid-use-disorder 2026-05-14T20:14:21Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-esketamine-for-reduction-of-symptoms-of-major 2026-05-14T20:14:21Z monthly 0.7 https://www.moreblossom.com/trials/neuroguard-psilocybin-trial-for-preventing-chemo-induced-neuropathy 2026-05-14T20:14:21Z monthly 0.7 https://www.moreblossom.com/trials/the-efficacy-and-safety-of-short-term-s-ketamine-infusion-as-an-adjunctive-therapy-in-patients-with-fibromyalgia 2026-05-07T16:17:28Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-assisted-psychotherapy-for-treatment-resistant-depression 2026-05-14T20:14:21Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-enhanced-therapy-for-individuals-with-alcohol-use-disorder-and-depression-a-pilot-study-ket-dual 2026-05-07T16:17:30Z monthly 0.7 https://www.moreblossom.com/trials/subanesthetic-esketamine-in-modified-ect-for-severe-depression-in-adolescents-clinical-and-mechanistic-study 2026-05-07T16:17:31Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-efficacy-of-lidocaine-versus-ketamine-infusion-for-resistant-orofacial-pain 2026-05-07T16:17:32Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-to-treat-depression-in-spinal-cord-injury 2026-05-14T20:14:21Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-preliminary-efficacy-of-organic-whole-psilocybin-containing-mushrooms-to-treat-patients-suffering-from-ptsd 2026-05-14T20:14:22Z monthly 0.7 https://www.moreblossom.com/trials/rct-of-psilocybin-assisted-cbt-for-depression 2026-05-14T20:14:22Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-massed-exposure-therapy-for-ptsd 2026-05-14T20:14:22Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-psychotherapy-for-the-treatment-of-severe-alcohol-use-disorder 2026-05-14T20:14:22Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-psilocybin-on-speech-fluency-struggle-and-brain-activity-in-people-who-stutter 2026-05-14T20:14:22Z monthly 0.7 https://www.moreblossom.com/trials/ecstasy-to-alleviate-severe-chronic-neuropathic-pain-trial 2026-05-07T16:17:38Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-2a-trial-of-mm402-for-autism-spectrum-disorder 2026-05-14T20:14:23Z monthly 0.7 https://www.moreblossom.com/trials/comparison-of-intranasal-ketorolac-and-intranasal-ketamine-in-digital-nerve-block-pain 2026-05-07T16:17:40Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-physical-therapy-in-chronic-low-back-pain 2026-05-14T20:14:23Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-biomarker-validation 2026-05-14T20:14:23Z monthly 0.7 https://www.moreblossom.com/trials/pharmacokinetics-of-didehydro-lsd-ddh-lsd-compared-with-lsd 2026-05-07T16:17:42Z monthly 0.7 https://www.moreblossom.com/trials/ayahuasca-esketamine-and-ptsd 2026-05-07T16:17:43Z monthly 0.7 https://www.moreblossom.com/trials/ayahuasca-esketamine-and-body-image-perception 2026-05-07T16:17:44Z monthly 0.7 https://www.moreblossom.com/trials/ayahuasca-esketamine-and-premenstrual-symptoms 2026-05-07T16:17:45Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-randomized-therapy 2026-05-14T20:14:23Z monthly 0.7 https://www.moreblossom.com/trials/group-retreat-psilocybin-therapy-for-the-treatment-of-anxiety-and-depression-in-patients-with-metastatic-solid-tumors-or 2026-05-14T20:14:24Z monthly 0.7 https://www.moreblossom.com/trials/salivary-oxytocin-as-a-biomarker-of-psychedelic-treatment 2026-05-07T16:17:48Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-whole-mushroom-for-the-treatment-of-obsessive-compulsive-disorder 2026-05-14T20:14:24Z monthly 0.7 https://www.moreblossom.com/trials/consciousness-and-psilocybin-effects-on-well-being-the-copewell-study 2026-05-14T20:14:24Z monthly 0.7 https://www.moreblossom.com/trials/targeting-treatment-resistant-oud-with-ketamine-assisted-mindfulness-oriented-recovery-enhancement 2026-05-14T20:14:24Z monthly 0.7 https://www.moreblossom.com/trials/esketamine-with-or-without-integration-therapy-for-treatment-resistant-depression 2026-05-07T16:17:51Z monthly 0.7 https://www.moreblossom.com/trials/understanding-music-and-mindfulness-preferences-in-psilocybin-assisted-psychotherapy 2026-05-07T16:17:52Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-psychedelics-in-healthy-older-adults-with-low-well-being 2026-05-14T20:14:24Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-psychotherapy-for-the-treatment-of-gambling-disorder-a-pilot-study 2026-05-07T16:17:54Z monthly 0.7 https://www.moreblossom.com/trials/psychotherapy-combined-with-intranasal-esketamine-for-the-treatment-of-suicidal-ideation 2026-05-14T20:14:25Z monthly 0.7 https://www.moreblossom.com/trials/a-clinical-trial-of-add-on-oral-slow-release-ketamine-treatment-in-major-depression 2026-05-07T16:17:56Z monthly 0.7 https://www.moreblossom.com/trials/mitochondrial-function-after-ketamine 2026-05-07T16:17:57Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-for-comorbid-major-depressive-disorder-and-alcohol-use-disorder 2026-05-07T16:17:58Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-after-trauma-surgery-for-pain 2026-05-14T20:14:25Z monthly 0.7 https://www.moreblossom.com/trials/the-role-of-coadministration-of-lidocaine-and-ketamine-in-opioid-refractory-chronic-cancer-related-pain 2026-05-07T16:17:59Z monthly 0.7 https://www.moreblossom.com/trials/virtual-reality-based-mindfulness-as-an-adjunct-to-treatment-as-usual-in-treatment-resistant-depression 2026-05-07T16:18:00Z monthly 0.7 https://www.moreblossom.com/trials/the-effects-of-psilocybin-in-healthy-volunteers-psychological-biochemical-and-electrophysiological-biomarkers 2026-05-07T16:18:01Z monthly 0.7 https://www.moreblossom.com/trials/acute-effects-of-intravenous-5-meo-dmt-in-healthy-participants 2026-05-07T16:18:02Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-microdosing-on-cognition-mood-and-quality-of-life 2026-05-14T20:14:25Z monthly 0.7 https://www.moreblossom.com/trials/optimal-timing-of-ketamine-initiation-for-scd-pain 2026-05-14T20:14:25Z monthly 0.7 https://www.moreblossom.com/trials/group-vs-individual-mdma-assisted-therapy-for-ptsd-after-the-october-7-2023-events 2026-05-07T16:18:05Z monthly 0.7 https://www.moreblossom.com/trials/anesthesia-masked-psilocybin-therapy-for-major-depression 2026-05-14T20:14:26Z monthly 0.7 https://www.moreblossom.com/trials/precision-phenotyping-of-behavioral-risk-and-response-to-electromagnetic-and-psychedelic-therapies 2026-05-07T16:18:07Z monthly 0.7 https://www.moreblossom.com/trials/elucidating-the-relevance-of-the-psychedelic-experience-to-psilocybins-anti-anhedonic-effects 2026-05-07T16:18:08Z monthly 0.7 https://www.moreblossom.com/trials/acute-analgesic-effects-of-mdma-on-experimentally-induced-acute-pain-hyperalgesia-and-allodynia-in-healthy-participants 2026-05-07T16:18:09Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-psychotherapy-for-treatment-resistant-depression-and-co-occurring-substance-use-disorder 2026-05-14T20:14:26Z monthly 0.7 https://www.moreblossom.com/trials/shortened-lsd-intervention-for-major-depressive-disorder 2026-05-14T20:14:26Z monthly 0.7 https://www.moreblossom.com/trials/investigating-the-analgesic-potential-of-2r6r-hnk-in-acute-pain-in-healthy-volunteers 2026-05-14T20:14:26Z monthly 0.7 https://www.moreblossom.com/trials/group-psilocybin-assisted-therapy-for-post-traumatic-stress-disorder 2026-05-07T16:18:12Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-tolerability-trial-of-psilocybin-in-healthy-older-adults 2026-05-14T20:14:27Z monthly 0.7 https://www.moreblossom.com/trials/electroconvulsive-therapy-versus-intravenous-ketamine-in-treatment-resistant-major-depressive-disorder 2026-05-07T16:18:14Z monthly 0.7 https://www.moreblossom.com/trials/atlas-1-advanced-trial-for-longitudinal-assessment-in-salma-1 2026-05-14T20:14:27Z monthly 0.7 https://www.moreblossom.com/trials/pharmacokinetics-and-safety-of-gh001-delivered-via-a-gh001-aerosol-delivery-system-in-healthy-subjects 2026-05-14T20:14:27Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-therapy-for-bn 2026-05-14T20:14:27Z monthly 0.7 https://www.moreblossom.com/trials/circulating-oxytocin-changes-in-response-to-mdma-vs-placebo-in-adult-patients-with-autism-spectrum-disorder-and-matched- 2026-05-07T16:18:17Z monthly 0.7 https://www.moreblossom.com/trials/inhaled-dmt-for-major-depressive-disorder 2026-05-07T16:18:19Z monthly 0.7 https://www.moreblossom.com/trials/kalm-b-ketamine-assisted-psychotherapy-kap-to-lessen-morbidity-after-burn-injury 2026-05-14T20:14:27Z monthly 0.7 https://www.moreblossom.com/trials/coaching-as-an-adjunct-to-ketamine-therapy-for-treatment-resistant-depression 2026-05-14T20:14:28Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-administration-with-5-ht1a-blockade 2026-05-14T20:14:28Z monthly 0.7 https://www.moreblossom.com/trials/group-retreat-psilocybin-therapy-for-healthcare-clinicians-with-loss-of-meaning-in-their-work-and-symptoms-of-depression 2026-05-11T13:10:52Z monthly 0.7 https://www.moreblossom.com/trials/group-pacbt-for-depression 2026-05-14T20:14:28Z monthly 0.7 https://www.moreblossom.com/trials/mdma-therapy-in-veterans-with-ptsd 2026-05-14T20:14:28Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-with-dialectical-behavioural-therapy-dbt-for-suicidality-in-individuals-with-treatment-resistant-depression-and 2026-05-11T12:37:05Z monthly 0.7 https://www.moreblossom.com/trials/redefine-study-a-study-evaluating-the-efficacy-safety-and-tolerability-of-comp360-in-participants-with-post-traumatic-st 2026-05-11T13:06:21Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-as-a-treatment-for-depression 2026-05-18T13:45:13Z monthly 0.7 https://www.moreblossom.com/trials/11c-r-rolipram-to-measure-camp-signaling-before-and-after-ketamine 2026-05-14T20:14:28Z monthly 0.7 https://www.moreblossom.com/trials/5-ht2a-agonist-psilocybin-in-the-treatment-of-tobacco-use-disorder 2026-05-14T20:14:29Z monthly 0.7 https://www.moreblossom.com/trials/a-24-week-multicentre-randomised-double-blind-placebo-controlled-parallel-group- 2026-03-24T14:45:01Z monthly 0.7 https://www.moreblossom.com/trials/a-clinical-trial-of-5-mg-psilocybin-plus-psychological-support-vs-25-mg-psilocyb 2026-05-07T16:18:45Z monthly 0.7 https://www.moreblossom.com/trials/a-clinical-trial-of-psilocybin-assisted-psychotherapy-as-a-treatment-for-anorexi 2026-05-07T19:03:25Z monthly 0.7 https://www.moreblossom.com/trials/a-community-of-practice-program-with-psilocybin-assisted-therapy-for-end-of-life 2026-05-07T16:13:38Z monthly 0.7 https://www.moreblossom.com/trials/a-dose-finding-and-proof-of-concept-study-of-the-efficacy-and-safety-of-msp-1014 2026-05-07T16:18:48Z monthly 0.7 https://www.moreblossom.com/trials/a-dose-finding-study-of-mm-120-for-the-treatment-of-anxiety-symptoms 2026-05-14T20:14:29Z monthly 0.7 https://www.moreblossom.com/trials/a-dose-ranging-study-of-50-ug-to-100-ug-lsd-in-healthy-volunteers 2026-05-07T16:12:54Z monthly 0.7 https://www.moreblossom.com/trials/a-double-blind-placebo-controlled-study-to-evaluate-very-low-dose-lsd-in-healthy 2026-05-07T16:09:27Z monthly 0.7 https://www.moreblossom.com/trials/a-double-blind-randomised-controlled-trial-of-the-efficacy-of-microdosing-with-p 2026-05-07T18:35:46Z monthly 0.7 https://www.moreblossom.com/trials/a-double-blind-randomised-trial-of-methylphenidate-assisted-versus-mdma-assisted 2026-05-07T19:02:14Z monthly 0.7 https://www.moreblossom.com/trials/a-double-blind-randomized-placebo-controlled-study-to-investigate-the-safety-tol 2026-05-07T18:35:31Z monthly 0.7 https://www.moreblossom.com/trials/a-double-blind-trial-of-psilocybin-assisted-treatment-of-alcohol-dependence 2026-05-14T20:14:29Z monthly 0.7 https://www.moreblossom.com/trials/a-feasibility-study-of-psychedelic-microdosing-assisted-meaning-centred-psychoth 2026-05-07T18:43:05Z monthly 0.7 https://www.moreblossom.com/trials/a-fixed-repeat-dose-study-of-comp360-for-treatment-resistant-depression-comp-006 2026-05-14T20:14:30Z monthly 0.7 https://www.moreblossom.com/trials/a-ketamine-assisted-group-therapy-intervention-for-spanish-speaking-adults-with- 2026-05-14T20:14:30Z monthly 0.7 https://www.moreblossom.com/trials/a-long-term-comparison-of-esketamine-nasal-spray-versus-quetiapine-extended-rele 2026-05-11T19:17:05Z monthly 0.7 https://www.moreblossom.com/trials/a-long-term-extension-study-for-participants-with-treatment-resistant-major-depr 2026-05-07T16:10:23Z monthly 0.7 https://www.moreblossom.com/trials/a-long-term-safety-and-efficacy-study-of-intranasal-esketamine-in-treatment-resi 2026-05-14T20:14:30Z monthly 0.7 https://www.moreblossom.com/trials/a-long-term-safety-study-of-esketamine-nasal-spray-in-treatment-resistant-depres 2026-05-14T20:14:30Z monthly 0.7 https://www.moreblossom.com/trials/a-longitudinal-open-label-dose-ranging-clinical-trial-to-evaluate-the-effectiven 2026-05-07T18:36:55Z monthly 0.7 https://www.moreblossom.com/trials/a-mechanistic-study-to-assess-a-single-dose-of-cyb003-in-participants-with-depre 2026-05-14T20:14:31Z monthly 0.7 https://www.moreblossom.com/trials/a-multi-center-randomized-subject-and-investigator-blinded-placebo-controlled-ac 2026-03-24T14:45:07Z monthly 0.7 https://www.moreblossom.com/trials/a-multi-site-expanded-access-program-for-mdma-assisted-psychotherapy-for-patient 2026-05-14T20:14:31Z monthly 0.7 https://www.moreblossom.com/trials/a-multi-site-open-label-extension-study-of-mdma-assisted-psychotherapy-for-ptsd 2026-05-14T20:14:31Z monthly 0.7 https://www.moreblossom.com/trials/a-multi-site-phase-3-study-of-mdma-assisted-psychotherapy-for-ptsd-mapp2 2026-05-14T20:14:32Z monthly 0.7 https://www.moreblossom.com/trials/a-multi-site-phase-3-study-of-mdma-assisted-psychotherapy-for-ptsd-mapp1 2026-05-14T20:14:32Z monthly 0.7 https://www.moreblossom.com/trials/a-multi-site-study-of-mdma-assisted-psychotherapy-for-eating-disorders 2026-05-07T16:09:34Z monthly 0.7 https://www.moreblossom.com/trials/a-multicentre-double-blind-randomised-placebo-controlled-phase-ii-study-mdd 2026-03-24T14:45:07Z monthly 0.7 https://www.moreblossom.com/trials/a-multicentre-double-blind-randomised-placebo-controlled-phase-ii-study-to-asses 2026-03-24T14:45:07Z monthly 0.7 https://www.moreblossom.com/trials/a-multicentre-double-blind-randomised-placebo-controlled-phase-ii-trial-with-a-3 2026-03-24T14:45:10Z monthly 0.7 https://www.moreblossom.com/trials/a-multimodal-neuroimaging-study-of-brain-activation-patterns-under-ketamine 2026-05-07T16:08:13Z monthly 0.7 https://www.moreblossom.com/trials/a-naturalistic-study-of-ketamine-for-treatment-resistant-mood-disorders 2026-05-12T14:53:33Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-1-open-label-dose-escalation-study-to-evaluate-the-safety-and-pharmacoki 2026-05-07T18:35:50Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-1-open-label-pilot-study-to-assess-the-safety-feasibility-and-initial-ef 2026-05-07T18:36:01Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-1-open-label-single-cohort-study-to-evaluate-the-safety-and-pharmacokine 2026-05-07T18:45:04Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-1-randomized-first-in-human-double-blind-placebo-controlled-study-to-eva 2026-05-07T18:35:33Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-1-single-centre-randomised-double-blind-placebo-controlled-single-ascend 2026-05-07T18:35:35Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-1b-study-of-psilocybin-assisted-psychotherapy-to-address-fear-of-recurre 2026-05-14T20:14:32Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-2-open-label-treatment-development-study-of-mdma-assisted-cognitive-proc 2026-05-07T16:11:03Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-2b-double-blind-randomized-low-dose-comparator-controlled-clinical-trial 2026-05-07T18:35:50Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-3-trial-of-mm120-for-major-depressive-disorder-emerge 2026-05-14T20:14:32Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-3-trial-to-assess-cyb003-in-major-depressive-disorder-embrace 2026-05-14T20:14:33Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-i-multi-centre-double-blind-placebo-controlled-parallel-group-study-to-a 2026-03-24T14:45:14Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-i-randomized-placebo-controlled-double-blind-single-ascending-dose-study 2026-05-07T19:02:52Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-ii-multicentre-randomised-double-blind-controlled-study-to-investigate-t 2026-05-14T20:14:33Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-ii-randomized-double-blind-active-placebo-controlled-paria 2026-03-24T14:45:14Z monthly 0.7 https://www.moreblossom.com/trials/a-phase-ii-randomized-double-blind-placebo-controlled-study-to-evaluate-the-effi 2026-05-14T20:14:33Z monthly 0.7 https://www.moreblossom.com/trials/a-pilot-study-on-oral-s-ketamine-for-depression-and-demoralization-in-patients-w 2026-03-24T14:45:14Z monthly 0.7 https://www.moreblossom.com/trials/a-pilot-study-testing-the-feasibility-of-a-single-microdose-of-ayahuasca-alkaloi 2026-05-07T18:42:52Z monthly 0.7 https://www.moreblossom.com/trials/a-preliminary-study-of-intravenous-ketamine-in-selective-serotonin-reuptake-inhi 2026-03-24T14:45:17Z monthly 0.7 https://www.moreblossom.com/trials/a-randomised-controlled-trial-of-oral-s-ketamine-as-add-on-medication-for-patien 2026-04-24T10:50:45Z monthly 0.7 https://www.moreblossom.com/trials/a-randomised-double-blind-active-placebo-controlled-crossover-trial-to-evaluate- 2026-05-12T14:30:37Z monthly 0.7 https://www.moreblossom.com/trials/a-randomised-double-blind-active-placebo-controlled-phase-2-pilot-study-of-mdma- 2026-05-07T19:00:17Z monthly 0.7 https://www.moreblossom.com/trials/a-randomised-double-blind-placebo-controlled-trial-to-study-the-effects-of-repea 2026-05-07T19:03:02Z monthly 0.7 https://www.moreblossom.com/trials/a-randomised-placebo-controlled-trial-of-psilocybin-in-treatment-resistant-depre 2026-05-07T16:10:47Z monthly 0.7 https://www.moreblossom.com/trials/a-randomized-double-blind-placebo-controlled-parallel-group-trial-to-evaluate-th 2026-03-24T14:45:17Z monthly 0.7 https://www.moreblossom.com/trials/a-randomized-neuroimaging-trial-of-psilocybin-in-depression 2026-05-07T16:14:06Z monthly 0.7 https://www.moreblossom.com/trials/a-randomized-placebo-controlled-double-blind-study-to-assess-safety-and-efficacy 2026-05-14T20:14:33Z monthly 0.7 https://www.moreblossom.com/trials/a-retrospective-effectiveness-trial-of-ketamine-assisted-psychotherapy-in-adult- 2026-05-14T20:14:34Z monthly 0.7 https://www.moreblossom.com/trials/a-second-psilocybin-group-therapy-for-the-treatment-of-cancer-related-anxiety-in 2026-05-14T20:14:34Z monthly 0.7 https://www.moreblossom.com/trials/a-single-dose-of-comp360-for-treatment-resistant-depression-comp005 2026-05-14T20:14:34Z monthly 0.7 https://www.moreblossom.com/trials/a-single-ketamine-infusion-combined-with-music-for-suicidal-ideation 2026-05-14T20:14:34Z monthly 0.7 https://www.moreblossom.com/trials/a-study-assessing-brain-activity-safety-tolerability-and-pharmacokinetics-follow 2026-05-07T16:17:12Z monthly 0.7 https://www.moreblossom.com/trials/a-study-carried-out-on-healthy-volunteers-to-understand-how-comp360-can-be-taken 2026-05-07T16:18:46Z monthly 0.7 https://www.moreblossom.com/trials/a-study-comparing-two-formulations-of-r-107-under-fasting-conditions 2026-05-07T18:35:57Z monthly 0.7 https://www.moreblossom.com/trials/a-study-in-healthy-male-volunteers-to-investigate-how-the-test-medicine-comp360- 2026-05-07T16:18:49Z monthly 0.7 https://www.moreblossom.com/trials/a-study-in-healthy-men-to-test-whether-bi-409306-bi-425809-or-lamotrigine-can-re 2026-05-14T20:14:35Z monthly 0.7 https://www.moreblossom.com/trials/a-study-in-healthy-volunteers-to-look-at-how-comp360-is-taken-up-by-the-body-whe 2026-05-07T16:18:46Z monthly 0.7 https://www.moreblossom.com/trials/a-study-into-the-safety-and-effects-of-psychotherapy-in-combination-with-mdma-as 2026-03-17T13:41:42Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-a-n-n-dimethyltryptamine-dmt-analog-cyb004-in-participants-with-gener 2026-05-14T20:14:35Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-a-psilocybin-analog-cyb003-in-humans-with-major-depressive-disorder-a 2026-05-14T20:14:35Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-a-psilocybin-analog-cyb003-in-participants-with-major-depressive-diso 2026-05-14T20:14:35Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-brexpiprazole-plus-ketamine-in-treatment-resistant-depression-trd 2026-05-14T20:14:36Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-cle-100-oral-esketamine-as-an-adjunctive-treatment-to-standard-antide 2026-05-14T20:14:36Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-different-oral-thin-film-s-ketamine-formulations-for-sublingual-admin 2026-05-07T16:09:17Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-esketamine-nasal-spray-administered-as-monotherapy-in-adult-participa 2026-05-14T20:14:36Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-esketamine-nasal-spray-in-korean-participants-with-treatment-resistan 2026-05-07T16:17:13Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-hr071603ketamine-nasal-spray-in-healthy-subjects 2026-05-07T16:08:54Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-ketamine-in-patients-with-treatment-resistant-depression 2026-05-14T20:14:36Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-ketamine-infusions-to-treat-clinically-depressed-icu-patients 2026-05-14T20:14:37Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-oral-ibogaine-in-opioid-withdrawal 2026-05-07T16:10:53Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-psilocybin-for-major-depressive-disorder-mdd 2026-05-14T20:14:37Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-psilocybin-for-ptsd-psi-3po 2026-05-14T20:14:37Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-sls-002-intranasal-racemic-ketamine-in-adults-with-major-depressive-d 2026-05-14T20:14:37Z monthly 0.7 https://www.moreblossom.com/trials/a-study-of-the-psychological-cognitive-and-physiological-effects-of-psychedelic- 2026-05-07T18:42:42Z monthly 0.7 https://www.moreblossom.com/trials/a-study-on-the-safety-and-effects-of-the-drug-dmt-in-healthy-smoking-individuals 2026-05-07T16:18:43Z monthly 0.7 https://www.moreblossom.com/trials/a-study-on-the-safety-tolerability-and-effects-of-gm-2505 2026-05-07T16:18:51Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-assess-18-methoxycoronaridine 2026-05-07T16:09:16Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-assess-feasibility-of-using-clinician-directed-and-digital-applicatio 2026-05-14T20:14:38Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-decrease-suicidal-thinking-using-ketamine 2026-05-14T20:14:38Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-evaluate-ketamine-for-the-treatment-of-rett-syndrome 2026-05-14T20:14:38Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-intranasal-esketamine-aspire-i 2026-05-14T20:14:38Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-intranasal-esketamine-in-addition 2026-05-14T20:14:39Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-evaluate-the-efficacy-pharmacokinetics-safety-and-tolerability-of-fle 2026-05-14T20:14:39Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-evaluate-the-efficacy-safety-and-tolerability-of-fixed-doses-of-intra 2026-05-14T20:14:39Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-evaluate-the-efficacy-safety-and-tolerability-of-flexible-doses-of-in 2026-05-14T20:14:39Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-evaluate-the-efficacy-safety-and-tolerability-of-intranasal-esketamin 2026-05-14T20:14:40Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-mls101-in-he 2026-05-07T16:14:49Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-multiple-dos 2026-05-07T16:15:52Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamic 2026-05-07T16:11:08Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-investigate-evoked-potentials-as-markers-of-ketamine-induced-cortical 2026-05-14T20:14:40Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-investigate-the-effects-of-repeated-low-doses-of-psilocybin-and-ketam 2026-03-24T14:25:35Z monthly 0.7 https://www.moreblossom.com/trials/a-study-to-investigate-the-safety-and-feasibility-of-delivering-mdma-assisted-ps 2026-05-07T18:45:58Z monthly 0.7 https://www.moreblossom.com/trials/a-test-of-mdma-assisted-psychotherapy-in-people-with-posttraumatic-stress 2026-05-14T20:14:40Z monthly 0.7 https://www.moreblossom.com/trials/a-trial-of-gh001-in-patients-with-treatment-resistant-depression 2026-05-07T16:13:15Z monthly 0.7 https://www.moreblossom.com/trials/abuse-liability-and-human-pharmacology-of-mephedrone 2026-05-07T16:06:30Z monthly 0.7 https://www.moreblossom.com/trials/abuse-potential-and-human-pharmacology-of-methylone 2026-05-07T16:12:19Z monthly 0.7 https://www.moreblossom.com/trials/acceptability-safety-of-two-sequential-doses-of-psilocybin-in-bipolar-disorder-i 2026-05-14T20:14:41Z monthly 0.7 https://www.moreblossom.com/trials/act_for-alcohol-use-disorder-and-depression 2026-05-07T16:15:48Z monthly 0.7 https://www.moreblossom.com/trials/action-of-ketamine-in-treatment-resistant-depression 2026-05-07T16:06:07Z monthly 0.7 https://www.moreblossom.com/trials/active-controlled-trial-of-a-ketamine-assisted-group-mindfulness-intervention-fo 2026-05-07T18:42:32Z monthly 0.7 https://www.moreblossom.com/trials/acute-analgesic-effects-of-dmt-on-experimentally-induced-pain-in-healthy-partici 2026-05-07T16:14:27Z monthly 0.7 https://www.moreblossom.com/trials/acute-dose-dependent-effects-of-dmt-bolus-applications-in-healthy-subjects-dmt-b 2026-05-07T16:12:55Z monthly 0.7 https://www.moreblossom.com/trials/acute-dose-dependent-effects-of-dmt-in-healthy-subjects-a-placebo-controlled-cro 2026-05-07T16:11:58Z monthly 0.7 https://www.moreblossom.com/trials/acute-effects-of-2c-b-compared-with-mdma-and-psilocybin-in-healthy-subjects-2c-b 2026-05-07T16:12:24Z monthly 0.7 https://www.moreblossom.com/trials/acute-effects-of-34-methylenedioxymethamphetamine-mdma-with-and-without-a-booste 2026-05-07T16:13:18Z monthly 0.7 https://www.moreblossom.com/trials/acute-effects-of-mdma-co-administration-on-the-response-to-psilocybin-in-healthy 2026-05-07T16:16:45Z monthly 0.7 https://www.moreblossom.com/trials/acute-effects-of-r-and-s-mdma-in-healthy-subjects-r-s-mdma 2026-05-07T16:11:40Z monthly 0.7 https://www.moreblossom.com/trials/add-on-therapy-with-edupression-com-on-therapy-resistant-depressive-patients-tre 2026-05-07T16:10:26Z monthly 0.7 https://www.moreblossom.com/trials/adding-trauma-focused-psychotherapy-to-ketamine-treatment-for-chronic-ptsd 2026-05-14T20:14:41Z monthly 0.7 https://www.moreblossom.com/trials/additional-mdma-assisted-psychotherapy-for-people-who-relapsed-after-mdma-assist 2026-05-14T20:14:41Z monthly 0.7 https://www.moreblossom.com/trials/adjunctive-effects-of-psilocybin-and-buprenorphine 2026-05-14T20:14:41Z monthly 0.7 https://www.moreblossom.com/trials/administration-of-psilocybe-cubensis-mushrooms-with-or-without-fluoxetine-with-o 2026-05-07T16:16:49Z monthly 0.7 https://www.moreblossom.com/trials/administration-of-subanesthetic-dose-of-ketamine-and-electroconvulsive-treatment 2026-05-14T20:14:41Z monthly 0.7 https://www.moreblossom.com/trials/alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic-acid-receptor-components-of 2026-05-14T20:14:42Z monthly 0.7 https://www.moreblossom.com/trials/an-eeg-study-of-intravenous-ketamine-for-major-depression-disorder 2026-05-07T16:12:21Z monthly 0.7 https://www.moreblossom.com/trials/an-efficacy-and-safety-of-proprietary-formulations-of-oral-ketamine-aspirin-in-t 2026-05-14T20:14:42Z monthly 0.7 https://www.moreblossom.com/trials/an-evaluation-of-psilocybins-effect-on-cardiac-repolarization 2026-05-14T20:14:42Z monthly 0.7 https://www.moreblossom.com/trials/an-expanded-access-protocol-for-esketamine-treatment-in-participants-with-treatm 2026-05-07T16:09:36Z monthly 0.7 https://www.moreblossom.com/trials/an-investigation-of-psilocybin-on-behavioural-and-cognitive-symptoms-of-adults-w 2026-05-07T16:13:20Z monthly 0.7 https://www.moreblossom.com/trials/an-open-label-clinical-trial-of-oral-ketamine-an-nmda-n-methyl-d-aspartate-recep 2026-05-12T14:05:06Z monthly 0.7 https://www.moreblossom.com/trials/an-open-label-dose-ranging-clinical-trial-of-oral-ketamine-an-nmda-n-methyl-d-as 2026-05-07T18:35:17Z monthly 0.7 https://www.moreblossom.com/trials/an-open-label-feasibility-study-of-ketamine-assisted-therapy-in-adults-with-trea 2026-05-07T18:37:09Z monthly 0.7 https://www.moreblossom.com/trials/an-open-label-feasibility-study-to-assess-the-safety-and-effect-of-manualised-md 2026-05-07T18:37:13Z monthly 0.7 https://www.moreblossom.com/trials/an-open-label-phase-2-feasibility-study-of-manualized-mdma-assisted-psychotherap 2026-05-19T08:55:37Z monthly 0.7 https://www.moreblossom.com/trials/an-open-label-single-dose-study-in-patients-with-alcohol-use-disorder 2026-05-07T16:12:54Z monthly 0.7 https://www.moreblossom.com/trials/an-open-label-study-of-the-efficacy-and-feasibility-of-psilocybin-assisted-psych 2026-05-12T20:28:46Z monthly 0.7 https://www.moreblossom.com/trials/an-open-label-study-of-the-safety-and-efficacy-of-psilocybin-in-participants-wit 2026-05-14T20:14:42Z monthly 0.7 https://www.moreblossom.com/trials/an-open-label-study-to-evaluate-the-safety-tolerability-and-subjective-effects-o 2026-05-07T18:42:34Z monthly 0.7 https://www.moreblossom.com/trials/an-open-prospective-trial-of-iv-ketamine-in-suicidal-adolescents 2026-05-14T20:14:42Z monthly 0.7 https://www.moreblossom.com/trials/animal-and-human-serotonergic-model-of-schizophrenia-validity-evaluated-by-qeeg- 2026-05-12T19:17:51Z monthly 0.7 https://www.moreblossom.com/trials/antidepressant-effects-of-ayahuasca-a-randomized-placebo-controlled-trial-in-tre 2026-05-07T16:07:22Z monthly 0.7 https://www.moreblossom.com/trials/antidepressant-response-of-dmt-masked-with-propofol-dmt4d 2026-05-07T16:16:57Z monthly 0.7 https://www.moreblossom.com/trials/effects-single-intravenous-arketamine-dose-trd-crossover 2026-05-12T05:34:13Z monthly 0.7 https://www.moreblossom.com/trials/assess-the-utility-of-a-speech-based-machine-learning-algorithm-to-predict-treat 2026-05-14T20:14:43Z monthly 0.7 https://www.moreblossom.com/trials/assessing-the-effects-of-lysergic-acid-diethylamide-lsd-microdosing-in-people-ex 2026-05-07T18:35:39Z monthly 0.7 https://www.moreblossom.com/trials/assessing-the-effects-of-lysergic-acid-diethylamide-lsd-microdosing-lsddep2 2026-05-07T19:04:07Z monthly 0.7 https://www.moreblossom.com/trials/assessing-the-efficacy-of-micro-dosed-psilocybin-on-reducing-anxiety-depression- 2026-05-07T16:10:51Z monthly 0.7 https://www.moreblossom.com/trials/assessing-the-pharmacokinetics-and-drug-interaction-liability-of-kratom-an-opioi 2026-05-14T20:14:43Z monthly 0.7 https://www.moreblossom.com/trials/assessment-of-psilocybin-trp-8802-in-concert-with-psychotherapy-in-patients-with 2026-05-14T20:14:43Z monthly 0.7 https://www.moreblossom.com/trials/auditory-mmn-eeg-in-trd-in-response-to-ketamine 2026-05-07T16:12:11Z monthly 0.7 https://www.moreblossom.com/trials/ayahuasca-assisted-psychotherapy-for-grief 2026-05-07T16:14:21Z monthly 0.7 https://www.moreblossom.com/trials/behavioral-and-electrophysiological-effects-of-ketamine-in-treatment-resistant-d 2026-05-14T20:14:43Z monthly 0.7 https://www.moreblossom.com/trials/behavioural-activation-therapy-and-esketamine-for-resistant-depression 2026-05-07T16:15:18Z monthly 0.7 https://www.moreblossom.com/trials/belief-updating-in-treatment-resistant-depression 2026-05-07T16:12:37Z monthly 0.7 https://www.moreblossom.com/trials/beyond-the-self-and-back-neuropharmacological-mechanisms-underlying-the-dissolut 2026-05-07T16:08:20Z monthly 0.7 https://www.moreblossom.com/trials/bioavailability-study-of-psilocybin-in-normal-adults 2026-05-14T20:14:43Z monthly 0.7 https://www.moreblossom.com/trials/biomarkers-of-fast-acting-therapies-in-major-depression 2026-05-14T20:14:44Z monthly 0.7 https://www.moreblossom.com/trials/biomarkers-of-response-to-ketamine-in-depression-mri-and-blood-assays-before-and 2026-05-14T20:14:44Z monthly 0.7 https://www.moreblossom.com/trials/bpl-003-efficacy-and-safety-in-treatment-resistant-depression 2026-05-14T20:14:44Z monthly 0.7 https://www.moreblossom.com/trials/brain-activity-effects-of-psychedelic-medicines-in-healthy-volunteers 2026-05-07T18:35:32Z monthly 0.7 https://www.moreblossom.com/trials/brain-injury-and-ketamine-a-prospective-randomized-controlled-double-blind-clini 2026-03-24T14:45:54Z monthly 0.7 https://www.moreblossom.com/trials/brain-network-dynamics-of-depression-during-esketamine-treatment 2026-05-14T20:14:44Z monthly 0.7 https://www.moreblossom.com/trials/can-a-low-dose-of-ketamine-change-how-people-with-treatment-resistant-depression 2026-05-07T16:18:51Z monthly 0.7 https://www.moreblossom.com/trials/can-a-one-off-administration-of-psilocybin-reduce-alcohol-intake-in-patients-wit 2026-04-24T10:50:45Z monthly 0.7 https://www.moreblossom.com/trials/can-memantine-prevent-memory-impairment-induced-by-mdma-in-humans 2026-03-17T13:43:34Z monthly 0.7 https://www.moreblossom.com/trials/can-memantine-prevent-memory-impairment-induced-by-mdma-in-humans-2 2026-03-17T13:43:36Z monthly 0.7 https://www.moreblossom.com/trials/cancer-related-major-depression-treated-with-a-single-dose-of-psilocybin-capsi 2026-05-07T16:14:48Z monthly 0.7 https://www.moreblossom.com/trials/characterization-of-altered-waking-states-of-consciousness-in-healthy-humans 2026-05-07T16:08:28Z monthly 0.7 https://www.moreblossom.com/trials/characterization-of-the-temporal-profile-of-the-anti-nociceptive-effect-of-ketam 2026-05-07T16:14:51Z monthly 0.7 https://www.moreblossom.com/trials/chart-review-of-patients-undergoing-ketamine-infusions 2026-05-12T10:28:31Z monthly 0.7 https://www.moreblossom.com/trials/chart-review-of-patients-undergoing-ketamine-treatments-for-depression 2026-05-07T16:17:20Z monthly 0.7 https://www.moreblossom.com/trials/circulating-oxytocin-changes-in-response-to-the-oxytocin-system-stimulator-mdma- 2026-05-07T16:09:57Z monthly 0.7 https://www.moreblossom.com/trials/clinical-and-mechanistic-effects-of-psilocybin-in-alcohol-addicted-patients 2026-05-12T22:51:08Z monthly 0.7 https://www.moreblossom.com/trials/clinical-and-neurobiological-predictors-of-response-to-ketamine-towards-personal 2026-03-24T14:45:58Z monthly 0.7 https://www.moreblossom.com/trials/clinical-neurocognitive-and-emotional-effects-of-psilocybin-in-depressed-patient 2026-05-13T07:51:45Z monthly 0.7 https://www.moreblossom.com/trials/clinical-study-of-dmt-in-healthy-adults 2026-05-07T16:12:36Z monthly 0.7 https://www.moreblossom.com/trials/clinical-study-of-gh001-in-depression 2026-05-07T16:10:05Z monthly 0.7 https://www.moreblossom.com/trials/clinical-trial-of-the-use-of-ketamine-in-treatment-resistant-depression 2026-05-07T16:07:03Z monthly 0.7 https://www.moreblossom.com/trials/cognitive-behavioral-therapy-following-esketamine-for-major-depression-and-suici 2026-05-14T20:14:44Z monthly 0.7 https://www.moreblossom.com/trials/cognitive-behavioral-therapy-in-prolonging-the-antidepressant-effects-of-intrave 2026-05-14T20:14:45Z monthly 0.7 https://www.moreblossom.com/trials/cognitive-recovery-after-electroconvulsive-therapy-and-general-anesthesia 2026-05-14T20:14:45Z monthly 0.7 https://www.moreblossom.com/trials/cognitive-therapy-to-sustain-the-antidepressant-effects-of-intravenous-ketamine- 2026-05-14T20:14:45Z monthly 0.7 https://www.moreblossom.com/trials/cognitive-training-as-an-adjunct-to-ketamine-in-real-world-clinics 2026-05-14T20:14:45Z monthly 0.7 https://www.moreblossom.com/trials/combined-ketamine-and-ecbt-intervention-for-ptsd 2026-05-07T16:10:18Z monthly 0.7 https://www.moreblossom.com/trials/combining-esketamine-and-prolonged-exposure-treatment-for-ptsd-post-traumatic-st 2026-05-14T20:14:46Z monthly 0.7 https://www.moreblossom.com/trials/come-closer-a-neurobiological-analysis-of-the-prosocial-effects-of-mdma 2026-03-17T13:43:56Z monthly 0.7 https://www.moreblossom.com/trials/comparative-acute-effects-of-lsd-psilocybin-and-mescaline 2026-05-07T16:09:08Z monthly 0.7 https://www.moreblossom.com/trials/comparative-acute-effects-of-r-mdma-and-s-mdma-in-healthy-participants-r-s 2026-05-07T16:16:54Z monthly 0.7 https://www.moreblossom.com/trials/comparative-effectiveness-of-ect-vs-ketamine-over-the-lifespan-reakt-sd 2026-05-14T20:14:46Z monthly 0.7 https://www.moreblossom.com/trials/comparative-effectiveness-study-of-two-forms-of-ketamine-for-treatment-resistant 2026-05-07T16:14:43Z monthly 0.7 https://www.moreblossom.com/trials/comparing-ketamine-and-propofol-anesthesia-for-electroconvulsive-therapy 2026-05-07T16:06:04Z monthly 0.7 https://www.moreblossom.com/trials/comparing-the-effects-of-psilocin-and-psilocybin-in-healthy-adults 2026-05-14T20:14:46Z monthly 0.7 https://www.moreblossom.com/trials/comparison-of-ketamine-and-esketamine-in-patients-suffering-from-fibromyalgia-sy 2026-05-07T16:10:43Z monthly 0.7 https://www.moreblossom.com/trials/computer-game-qualitative-and-meg-eeg-assessment-of-serotonergic-psychedelics 2026-05-14T20:14:46Z monthly 0.7 https://www.moreblossom.com/trials/connectivity-changes-associated-with-ketamine-assisted-psychotherapy-for-ptsd 2026-05-14T20:14:47Z monthly 0.7 https://www.moreblossom.com/trials/conscious-dying-conscious-living-ketamine-assisted-psychotherapy 2026-05-07T16:11:24Z monthly 0.7 https://www.moreblossom.com/trials/consciousness-and-psilocybin-effects-on-well-being-pilot-phase-cope-pilot 2026-05-14T20:14:47Z monthly 0.7 https://www.moreblossom.com/trials/continuation-ketamine-in-major-depression 2026-05-14T20:14:47Z monthly 0.7 https://www.moreblossom.com/trials/d-cycloserine-for-relapse-prevention-following-intravenous-ketamine-in-treatment 2026-05-07T16:07:16Z monthly 0.7 https://www.moreblossom.com/trials/department-of-defense-ptsd-adaptive-platform-trial-intervention-d-sls-002 2026-05-14T20:14:48Z monthly 0.7 https://www.moreblossom.com/trials/developing-optimal-psychedelic-assisted-psychotherapy-for-obsessive-compulsive-d 2026-05-07T18:42:37Z monthly 0.7 https://www.moreblossom.com/trials/digital-intervention-for-psychedelic-preparation-dipp-comparing-meditation-and-m 2026-05-07T16:16:35Z monthly 0.7 https://www.moreblossom.com/trials/direct-comparison-of-altered-states-of-consciousness-induced-by-lsd-and-psilocyb 2026-05-07T16:08:11Z monthly 0.7 https://www.moreblossom.com/trials/direct-comparison-of-altered-states-of-consciousness-induced-by-lsd-psilocybin-a 2026-05-07T16:16:51Z monthly 0.7 https://www.moreblossom.com/trials/does-psilocybin-alter-the-brains-response-to-food-choice-and-reward 2026-05-07T18:37:50Z monthly 0.7 https://www.moreblossom.com/trials/does-psilocybin-change-synaptic-density-in-amnestic-mild-cognitive-impairment 2026-05-07T16:13:57Z monthly 0.7 https://www.moreblossom.com/trials/does-psilocybin-require-psychedelic-effects-to-treat-depression-psi-ris 2026-05-07T16:13:01Z monthly 0.7 https://www.moreblossom.com/trials/does-serotonin-system-stimulation-increase-pro-social-behavior-a-comparative-pha 2026-05-07T16:14:08Z monthly 0.7 https://www.moreblossom.com/trials/dose-finding-pkpd-trial-for-re02-in-healthy-subjects 2026-05-07T16:13:43Z monthly 0.7 https://www.moreblossom.com/trials/dose-finding-study-for-the-combination-of-dmt-and-harmine-in-healthy-subjects-dh 2026-05-07T16:13:19Z monthly 0.7 https://www.moreblossom.com/trials/dose-low-dose-ketamine-in-casesarian 2026-05-07T16:14:39Z monthly 0.7 https://www.moreblossom.com/trials/dose-optimization-of-mdma-assisted-therapy-for-ptsd-dosop 2026-05-14T20:14:48Z monthly 0.7 https://www.moreblossom.com/trials/dose-response-study-of-mdma-assisted-psychotherapy-in-people-with-ptsd 2026-05-14T20:14:48Z monthly 0.7 https://www.moreblossom.com/trials/double-blind-placebo-controlled-trial-of-ketamine-therapy-in-treatment-resistant 2026-05-14T20:14:48Z monthly 0.7 https://www.moreblossom.com/trials/double-blind-trial-of-ketamine-therapy-plus-or-minus-naltrexone-in-treatment-res 2026-05-14T20:14:48Z monthly 0.7 https://www.moreblossom.com/trials/drug-effects-on-interpersonal-interaction 2026-05-14T20:14:49Z monthly 0.7 https://www.moreblossom.com/trials/drug-effects-on-mood-and-behavior-expectancy-mesa-x 2026-05-14T20:14:49Z monthly 0.7 https://www.moreblossom.com/trials/early-effects-of-ketamine-vs-placebo-with-venlafaxine-in-severe-depression-patie 2026-05-07T16:15:29Z monthly 0.7 https://www.moreblossom.com/trials/ect-vs-esketamine 2026-05-07T16:10:41Z monthly 0.7 https://www.moreblossom.com/trials/ect-with-ketamine-anesthesia-vs-high-intensity-ketamine-with-ect-rescue-for-trea 2026-05-07T16:07:47Z monthly 0.7 https://www.moreblossom.com/trials/eeg-characteristics-in-ect 2026-05-14T20:14:49Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-esketamine-on-conscious-state-in-patients-with-pdoc 2026-05-07T16:15:05Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-esketamine-on-depressive-symptoms-of-obese-patients-undergoing-laparos 2026-05-07T16:14:28Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-esketamine-on-postoperative-depression-gut-microbiota-bispectral-index 2026-05-07T16:09:18Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-esketamine-on-reducing-postoperative-anxiety-and-depression-in-adolesc 2026-05-07T16:14:07Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-intravenous-s-ketamine-on-opioid-consumption 2026-05-07T16:11:00Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-ketamine-and-etomidate-during-rsi-on-long-term-outcomes-rsi-lto 2026-05-14T20:14:49Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-ketamine-in-depressive-symptoms-of-elderly-patients-with-visual-impair 2026-05-07T16:08:05Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-ketamine-on-anxiety-ratings-in-patients-with-anxiety-disorders 2026-05-07T18:35:11Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-ketamine-on-neurological-activity-as-measured-by-electroencephalogram- 2026-05-14T20:14:50Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-ketamine-vs-active-placebo-on-suicidal-ideation-in-depressed-inpatient 2026-05-07T16:07:02Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-ketanserin-after-lsd-administration 2026-05-07T16:09:44Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-ketanserin-olanzapine-and-lorazepam-after-lsd-administration-on-the-ac 2026-05-07T16:13:40Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-lithium-versus-placebo-in-adults-with-treatment-resistant-depression-w 2026-05-14T20:14:50Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-low-dose-esketamine-on-delirium-in-high-risk-elderly-patients-undergoi 2026-05-07T16:16:38Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-low-dose-esketamine-on-maternal-depression-at-2-years-after-childbirth 2026-05-07T16:12:58Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-low-dose-esketamine-on-postoperative-depression-in-patients-with-breas 2026-05-07T16:10:31Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-methylenedioxymethamphetamine-mdma-serotonin-release-on-fear-extinctio 2026-05-07T16:08:07Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-psilocybin-on-the-positive-valence-system-in-treatment-resistant-depre 2026-05-07T16:15:55Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-psilocybin-only-and-psilocybin-assisted-cognitive-behavioral-therapy-i 2026-05-07T16:16:14Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-psychedelic-vr-augmented-therapy-on-patients-with-clinical-depression 2026-05-07T16:14:25Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-ssris-on-response-to-psilocybin-therapy 2026-05-07T16:12:42Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-stimulant-drugs-on-social-perception 2026-05-14T20:14:50Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-subanesthetic-dose-of-ketamine-combined-with-propofol-on-cognitive-fun 2026-05-07T16:06:36Z monthly 0.7 https://www.moreblossom.com/trials/effect-of-the-addition-of-ketamine-to-sevoflurane-anesthesia-in-electroconvulsiv 2026-05-07T16:06:32Z monthly 0.7 https://www.moreblossom.com/trials/effectiveness-of-ketamine-for-depression-and-suicidal-ideation-in-the-emergency- 2026-05-14T20:14:50Z monthly 0.7 https://www.moreblossom.com/trials/effectiveness-of-ketamine-therapy-among-patients-with-treatment-resistant-depression-a-double 2026-05-12T05:54:54Z monthly 0.7 https://www.moreblossom.com/trials/effectiveness-of-ketamine-treatment-for-three-consecutive-days-in-depression 2026-05-07T16:10:53Z monthly 0.7 https://www.moreblossom.com/trials/effectiveness-of-psychedelic-therapy-for-post-traumatic-stress-disorder-ptsd 2026-05-07T18:35:48Z monthly 0.7 https://www.moreblossom.com/trials/effectiveness-of-psychedelic-therapy-for-treatment-resistant-depression-trd 2026-05-07T19:03:57Z monthly 0.7 https://www.moreblossom.com/trials/effects-and-therapeutic-potential-of-psilocybin-in-alcohol-dependence 2026-05-14T20:14:50Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-5-meo-dmt-administered-by-intramuscul 2026-05-07T18:35:44Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-alcohol-0-5-0-and-mdma-100-mg-on-simulated-driving-performance-drivin 2026-03-17T13:45:12Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-dimethyltryptamine-in-healthy-subjects 2026-05-07T16:09:22Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-drugs-on-responses-to-brain-and-emotional-processes 2026-05-14T20:14:50Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-esketamine-on-postpartum-depression 2026-05-07T16:11:31Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-hallucinogens-and-other-drugs-on-mood-and-performance 2026-05-14T20:14:51Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-intranasal-ketamine-on-depression-and-anxiety-in-palliative-care-canc 2026-05-07T16:15:58Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-ketamine-on-mentalizing-and-metacognition-in-healthy-volunteers 2026-05-07T16:11:46Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-low-dose-intramuscular-ketamine-on-depression-ratings-in-depressed-pa 2026-05-07T18:39:33Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-low-dose-ketamine-as-an-adjunct-to-propofol-based-anesthesia-for-elec 2026-05-12T10:09:45Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-low-dose-ketamine-given-at-induction-of-anesthesia-on-postoperative-m 2026-05-14T20:14:51Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-lsd-on-neuroplasticity-in-healthy-subjects 2026-05-07T16:11:20Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-mdma-and-methylphenidate-on-social-cognition 2026-05-07T16:05:44Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-mdma-co-administration-on-the-response-to-lsd-in-healthy-subjects 2026-05-07T16:09:41Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-mdma-like-substances-in-healthy-subjects 2026-05-07T16:10:27Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-mdma-on-emotional-and-social-memories 2026-05-07T16:07:32Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-mdma-on-social-and-emotional-processing 2026-05-14T20:14:51Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-methylphenidate-modafinil-and-mdma-on-emotion-processing-in-humans-a- 2026-05-07T16:06:08Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-psilocybin-facilitated-experience-on-the-psychology-and-effectiveness 2026-05-14T20:14:51Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-psilocybin-in-advanced-stage-cancer-patients-with-anxiety 2026-05-14T20:14:51Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-psilocybin-in-anorexia-nervosa 2026-05-14T20:14:52Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-psilocybin-in-concussion-headache 2026-05-14T20:14:52Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-psilocybin-in-major-depressive-disorder 2026-05-14T20:14:52Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-psilocybin-in-obsessive-compulsive-disorder 2026-05-14T20:14:52Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-psilocybin-in-patients-with-amyotrophic-lateral-sclerosis 2026-05-14T20:14:52Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-psilocybin-in-post-treatment-lyme-disease 2026-05-14T20:14:53Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-psilocybin-on-behavior-psychology-and-brain-function-in-long-term-med 2026-05-14T20:14:53Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-psilocybin-on-electrophysiology-and-the-dynamic-content-of-thought 2026-05-14T20:14:53Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-psilocybin-on-shared-experience 2026-05-07T16:15:35Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-repeated-psilocybin-dosing-in-ocd 2026-05-14T20:14:53Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-salvinorin-a-in-healthy-controls 2026-05-14T20:14:54Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-salvinorin-a-on-brain-function 2026-05-14T20:14:54Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-sert-inhibition-on-the-subjective-response-to-lsd-in-healthy-subjects 2026-05-07T16:11:18Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-sert-inhibition-on-the-subjective-response-to-psilocybin-in-healthy-s 2026-05-07T16:08:34Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-sevoflurane-and-ketamine-on-qt-in-electroconvulsive-therapy 2026-05-07T16:05:59Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-stimulants-on-behavioral-and-neural-markers-of-social-motivation-abil 2026-05-14T20:14:54Z monthly 0.7 https://www.moreblossom.com/trials/effects-of-subanesthetic-dose-of-ketamine-given-on-postoperative-mood-in-patient 2026-05-07T16:13:08Z monthly 0.7 https://www.moreblossom.com/trials/efficacy-and-feasibility-of-intranasal-ketamine-on-acute-suicidality-a-double-bl 2026-04-24T10:50:45Z monthly 0.7 https://www.moreblossom.com/trials/efficacy-and-safety-of-comp360-psilocybin-therapy-in-anorexia-nervosa-a-proof-of 2026-05-14T20:14:54Z monthly 0.7 https://www.moreblossom.com/trials/efficacy-and-safety-of-psilocybin-in-treatment-resistant-major-depression 2026-05-07T16:10:03Z monthly 0.7 https://www.moreblossom.com/trials/efficacy-and-tolerability-of-psilocybin-assisted-physiotherapy-on-motor-symptoms 2026-05-07T18:42:28Z monthly 0.7 https://www.moreblossom.com/trials/efficacy-and-tolerability-of-sub-anesthetic-ketamine-in-postpartum-depression 2026-05-14T20:14:54Z monthly 0.7 https://www.moreblossom.com/trials/efficacy-of-intranasal-ketamine-on-acute-suicidality-a-double-blind-randomized-p 2026-04-24T10:50:45Z monthly 0.7 https://www.moreblossom.com/trials/efficacy-of-ketamine-for-the-prevention-of-relapse-in-patients-with-opioid-use-d 2026-03-24T14:46:36Z monthly 0.7 https://www.moreblossom.com/trials/efficacy-of-psilocybin-in-ocd-a-double-blind-placebo-controlled-study 2026-05-14T20:14:55Z monthly 0.7 https://www.moreblossom.com/trials/efficacy-of-repeated-ketamine-infusions-for-treatment-resistant-depression 2026-05-14T20:14:55Z monthly 0.7 https://www.moreblossom.com/trials/efficacy-of-sublingual-5-meo-dmt-for-reducing-anxiety-and-depression-in-mci-5-me 2026-05-07T16:16:33Z monthly 0.7 https://www.moreblossom.com/trials/ele-101-safety-tolerability-study-in-healthy-participants 2026-05-07T16:12:07Z monthly 0.7 https://www.moreblossom.com/trials/elekt-d-electroconvulsive-therapy-ect-vs-ketamine-in-patients-with-treatment-res 2026-05-14T20:14:55Z monthly 0.7 https://www.moreblossom.com/trials/emergency-ketamine-treatment-of-suicidal-ideation 2026-05-14T20:14:55Z monthly 0.7 https://www.moreblossom.com/trials/emotional-effects-of-methylphenidate-and-mdma-in-healthy-subjects 2026-05-07T16:05:34Z monthly 0.7 https://www.moreblossom.com/trials/endogenous-opioid-modulation-by-ketamine 2026-05-14T20:14:55Z monthly 0.7 https://www.moreblossom.com/trials/enhancing-week-long-psychological-treatment-for-ptsd-with-ketamine 2026-05-14T20:14:56Z monthly 0.7 https://www.moreblossom.com/trials/entheogen-resurgence 2026-05-14T20:14:56Z monthly 0.7 https://www.moreblossom.com/trials/epigenetics-and-mdma-assisted-psychotherapy-for-ptsd 2026-05-14T20:14:56Z monthly 0.7 https://www.moreblossom.com/trials/esketamine-adjuvant-therapy-for-patients-with-chronic-visceral-pain-comorbid-maj 2026-05-07T16:10:28Z monthly 0.7 https://www.moreblossom.com/trials/esketamine-and-perioperative-depressive-symptoms 2026-05-07T16:09:29Z monthly 0.7 https://www.moreblossom.com/trials/esketamine-for-fibromyalgia-treatment 2026-05-07T16:09:32Z monthly 0.7 https://www.moreblossom.com/trials/esketamine-for-the-treatment-of-rett-syndrome 2026-05-07T16:14:29Z monthly 0.7 https://www.moreblossom.com/trials/esketamine-on-postpartum-depression-in-cesarean-section-women 2026-05-07T16:10:32Z monthly 0.7 https://www.moreblossom.com/trials/esketamine-treatment-for-depressive-episodes-with-suicidal-ideation-in-mood-diso 2026-05-07T16:14:54Z monthly 0.7 https://www.moreblossom.com/trials/estimate-the-efficiency-of-the-association-of-an-injection-of-ketamine-and-the-v 2026-05-07T16:05:40Z monthly 0.7 https://www.moreblossom.com/trials/evaluating-the-atittudes-of-australian-psychologists-psychiatrists-and-mental-he 2026-05-07T18:42:11Z monthly 0.7 https://www.moreblossom.com/trials/evaluating-the-efficacy-of-psilocybin-assisted-psychotherapy-in-treatment-resist 2026-05-07T18:43:44Z monthly 0.7 https://www.moreblossom.com/trials/evaluating-the-positioning-of-esketamine-treatment-poet-for-symptom-management-i 2026-05-07T18:35:46Z monthly 0.7 https://www.moreblossom.com/trials/evaluation-of-mdma-on-startle-response 2026-05-14T20:14:56Z monthly 0.7 https://www.moreblossom.com/trials/evaluation-of-psilocybin-assisted-psychotherapy-in-treating-severe-depression-in 2026-05-07T16:14:20Z monthly 0.7 https://www.moreblossom.com/trials/evaluation-of-psilocybin-assisted-psychotherapy-pap-for-the-treatment-of-post-tr 2026-05-07T16:13:28Z monthly 0.7 https://www.moreblossom.com/trials/evaluation-of-psilocybin-in-anorexia-nervosa-safety-and-efficacy 2026-05-14T20:14:56Z monthly 0.7 https://www.moreblossom.com/trials/evaluation-of-psilocybin-trp-8802-to-decrease-hyperphagia 2026-05-14T20:14:57Z monthly 0.7 https://www.moreblossom.com/trials/evaluation-of-safety-rate-and-extent-of-absorption-of-psilocin-mucate-psilocin-1 2026-05-07T16:13:54Z monthly 0.7 https://www.moreblossom.com/trials/evaluation-of-schemes-of-administration-of-intravenous-ketamine-in-depression 2026-05-07T16:08:21Z monthly 0.7 https://www.moreblossom.com/trials/evaluation-of-the-effect-of-a-single-dose-of-psilocybin-on-neural-correlates-of- 2026-05-07T16:15:54Z monthly 0.7 https://www.moreblossom.com/trials/evaluation-of-the-efficacy-and-safety-of-subcutaneous-ketamine-in-the-treatment- 2026-05-07T16:17:02Z monthly 0.7 https://www.moreblossom.com/trials/evaluation-of-the-initial-prescription-of-ketamine-and-milnacipran-in-depression 2026-05-07T16:07:18Z monthly 0.7 https://www.moreblossom.com/trials/examining-34-methylenedioxymethamphetamine-mdma-effects-on-psychological-relatio 2026-05-07T16:15:06Z monthly 0.7 https://www.moreblossom.com/trials/examining-mu-opioid-mechanisms-of-ketamines-rapid-effects-in-ocd-mket2-mket2 2026-05-14T20:14:57Z monthly 0.7 https://www.moreblossom.com/trials/examining-the-effect-of-ketamine-on-glutamate-glutamine-cycling 2026-05-14T20:14:57Z monthly 0.7 https://www.moreblossom.com/trials/examining-the-impact-of-sirolimus-on-ketamines-antidepressant-effects 2026-05-14T20:14:57Z monthly 0.7 https://www.moreblossom.com/trials/exploration-of-synaptotrophic-effects-of-psilocybin-in-opioid-use-disorder-oud 2026-05-14T20:14:57Z monthly 0.7 https://www.moreblossom.com/trials/exploratory-safety-and-efficacy-of-emp-01-in-social-anxiety-disorder 2026-05-07T16:16:03Z monthly 0.7 https://www.moreblossom.com/trials/exploratory-study-of-low-dose-psilocybin 2026-05-14T20:14:58Z monthly 0.7 https://www.moreblossom.com/trials/exploratory-trial-to-assess-the-efficacy-and-safety-of-psilocybin-assisted-psych 2026-05-07T19:03:28Z monthly 0.7 https://www.moreblossom.com/trials/exploring-mechanisms-of-action-in-mdma-assisted-psychotherapy-for-ptsd 2026-05-14T20:14:58Z monthly 0.7 https://www.moreblossom.com/trials/exploring-medically-perceived-benefits-use-and-interest-in-psychedelics-and-cann 2026-05-07T16:10:48Z monthly 0.7 https://www.moreblossom.com/trials/feasibility-and-safety-of-ketamine-for-suicidal-patients-in-the-emergency-depart 2026-05-14T20:14:58Z monthly 0.7 https://www.moreblossom.com/trials/feasibility-clinical-effects-and-safety-of-psilocybin-assisted-psychotherapy-for 2026-05-07T16:14:44Z monthly 0.7 https://www.moreblossom.com/trials/feasibility-of-oral-ketamine-for-bipolar-depression-a-20-week-open-label-study 2026-05-07T18:35:59Z monthly 0.7 https://www.moreblossom.com/trials/feasibility-study-testing-the-protocol-of-single-dose-of-psilocybin-given-to-peo 2026-05-07T18:44:34Z monthly 0.7 https://www.moreblossom.com/trials/fifo-pat-20-a-sequential-multiple-assignment-randomised-controlled-trial-compari 2026-05-07T18:45:17Z monthly 0.7 https://www.moreblossom.com/trials/fixed-order-open-label-dose-escalation-study-of-dmt-in-humans 2026-05-14T20:14:58Z monthly 0.7 https://www.moreblossom.com/trials/fmri-of-patients-receiving-iv-ketamine-for-treatment-resistant-bipolar-depressio 2026-05-14T20:14:58Z monthly 0.7 https://www.moreblossom.com/trials/food-effects-on-bioavailability-of-mdma-in-healthy-volunteers-mpkf 2026-05-14T20:14:59Z monthly 0.7 https://www.moreblossom.com/trials/frontline-clinician-psilocybin-study 2026-05-14T20:14:59Z monthly 0.7 https://www.moreblossom.com/trials/functional-brain-imaging-in-recreational-users-of-ecstasy 2026-03-10T08:27:06Z monthly 0.7 https://www.moreblossom.com/trials/gamma-oscillations-as-a-prognostic-marker-for-ketamine-therapy-in-treatment-resi 2026-05-14T20:14:59Z monthly 0.7 https://www.moreblossom.com/trials/gluesk-glutamate-and-esketamine-gluesk 2026-05-07T16:15:19Z monthly 0.7 https://www.moreblossom.com/trials/glutamate-and-opioid-mechanisms-of-antidepressant-response-to-ketamine 2026-05-07T16:10:49Z monthly 0.7 https://www.moreblossom.com/trials/glutamate-emotion-memory-study 2026-05-07T16:13:19Z monthly 0.7 https://www.moreblossom.com/trials/glutamatergic-adaptation-to-stress-as-a-mechanism-for-anhedonia-and-treatment-re 2026-05-14T20:14:59Z monthly 0.7 https://www.moreblossom.com/trials/glutamatergic-mechanisms-of-psychosis-and-target-engagement-sa1 2026-05-14T20:14:59Z monthly 0.7 https://www.moreblossom.com/trials/group-mdma-therapy-for-veterans-with-ptsd-group-mvp 2026-05-14T20:15:00Z monthly 0.7 https://www.moreblossom.com/trials/high-intensity-inpatient-mdma-assisted-psychotherapy-for-ptsd-hi-map 2026-05-07T16:17:01Z monthly 0.7 https://www.moreblossom.com/trials/human-psychopharmacology-of-salvinorin-a 2026-05-14T20:15:00Z monthly 0.7 https://www.moreblossom.com/trials/hyperventilation-combined-with-etomidate-or-ketamine-anesthesia-in-ect-treatment 2026-05-07T16:07:23Z monthly 0.7 https://www.moreblossom.com/trials/i-cbt-and-iv-ketamine-for-suicidality-in-treatment-resistant-depression-a-random 2026-05-07T16:15:26Z monthly 0.7 https://www.moreblossom.com/trials/ibogaine-in-the-treatment-of-alcoholism-a-randomized-double-blind-placebo-contro 2026-05-07T16:07:57Z monthly 0.7 https://www.moreblossom.com/trials/im-and-iv-spl026-drug-product-in-healthy-participants 2026-05-07T16:12:49Z monthly 0.7 https://www.moreblossom.com/trials/im-ketamine-vs-midazolam-for-suicidal-er-patients 2026-05-14T20:15:00Z monthly 0.7 https://www.moreblossom.com/trials/imaging-neural-correlates-of-ketamine-using-pet-mr 2026-05-07T16:09:47Z monthly 0.7 https://www.moreblossom.com/trials/imaging-sv2a-in-mood-disorders 2026-05-14T20:15:00Z monthly 0.7 https://www.moreblossom.com/trials/imaging-the-effects-of-serotonin-2a-receptor-modulation-on-synaptic-density-in-t 2026-05-07T16:15:32Z monthly 0.7 https://www.moreblossom.com/trials/impact-of-ketamine-on-depressive-symptoms-in-patients-undergoing-lumbo-peritonea 2026-05-07T16:14:00Z monthly 0.7 https://www.moreblossom.com/trials/influence-of-bupropion-on-the-effects-of-mdma 2026-05-07T16:05:52Z monthly 0.7 https://www.moreblossom.com/trials/initiating-ketamine-in-acutely-suicidal-patients-in-the-emergency-department 2026-05-14T20:15:00Z monthly 0.7 https://www.moreblossom.com/trials/inpatient-buprenorphine-induction-with-psilocybin-for-opioid-use-disorder-bipod- 2026-05-14T20:15:01Z monthly 0.7 https://www.moreblossom.com/trials/inpatient-single-dose-interventions-for-alcohol-use-disorder 2026-05-14T20:15:01Z monthly 0.7 https://www.moreblossom.com/trials/integrating-ketamine-effects-on-neuronal-molecular-signatures-and-the-brain-func 2026-05-14T20:15:01Z monthly 0.7 https://www.moreblossom.com/trials/intensified-pharmacological-treatment-for-schizophrenia-major-depressive-disorde 2026-05-07T16:12:44Z monthly 0.7 https://www.moreblossom.com/trials/interaction-between-duloxetine-and-34-methylenedioxymethamphetamine-mdma-ecstasy 2026-05-07T16:05:12Z monthly 0.7 https://www.moreblossom.com/trials/interaction-between-reboxetine-and-34-methylenedioxymethamphetamine-pharmacodyna 2026-05-07T16:05:07Z monthly 0.7 https://www.moreblossom.com/trials/interactions-between-34-methylenedioxymethamphetamine-mdma-or-ecstasy-and-a9-tet 2026-03-17T13:47:22Z monthly 0.7 https://www.moreblossom.com/trials/intra-nasal-vs-intra-venous-ketamine-administration 2026-05-07T16:07:04Z monthly 0.7 https://www.moreblossom.com/trials/intramuscular-ketamine-for-suicidal-ideation 2026-05-14T20:15:01Z monthly 0.7 https://www.moreblossom.com/trials/intramuscular-ketamine-versus-aripiprazole-and-escitalopram-in-the-treatment-of- 2026-05-07T16:09:09Z monthly 0.7 https://www.moreblossom.com/trials/intranasal-esketamine-to-maintain-the-antidepressant-response-to-iv-racemic-keta 2026-05-14T20:15:02Z monthly 0.7 https://www.moreblossom.com/trials/intranasal-ketamine-for-late-life-depression-and-suicidal-ideation 2026-05-07T16:06:35Z monthly 0.7 https://www.moreblossom.com/trials/intranasal-ketamine-in-the-treatment-of-pediatric-bipolar-disorder 2026-05-14T20:15:02Z monthly 0.7 https://www.moreblossom.com/trials/intranasal-ketamine-in-treatment-resistant-depression 2026-05-14T20:15:02Z monthly 0.7 https://www.moreblossom.com/trials/intranasal-ketamine-in-ultra-resistant-depression-sure-ect-non-responders-sure-e 2026-05-07T16:11:10Z monthly 0.7 https://www.moreblossom.com/trials/intraoperative-ketamine-versus-saline-in-depressed-patients-undergoing-anesthesi 2026-05-14T20:15:02Z monthly 0.7 https://www.moreblossom.com/trials/intravenous-esketamine-on-prevention-of-postoperative-depression-in-patients-und 2026-05-07T16:11:13Z monthly 0.7 https://www.moreblossom.com/trials/intravenous-ketamine-and-immersive-virtual-reality-to-treat-depression-treasure 2026-05-07T16:16:19Z monthly 0.7 https://www.moreblossom.com/trials/intravenous-ketamine-effects-on-functional-neuroanatomy 2026-05-14T20:15:02Z monthly 0.7 https://www.moreblossom.com/trials/intravenous-ketamine-for-treatment-resistant-depression-exploring-biomarkers-of- 2026-03-24T14:47:06Z monthly 0.7 https://www.moreblossom.com/trials/intravenous-ketamine-for-treatment-resistant-depression-g2k 2026-05-14T20:15:03Z monthly 0.7 https://www.moreblossom.com/trials/intravenous-ketamine-plus-neurocognitive-training-for-depression 2026-05-14T20:15:03Z monthly 0.7 https://www.moreblossom.com/trials/investigating-the-impact-of-of-psilocybin-and-guided-meditation-on-brain-connect 2026-05-07T18:35:29Z monthly 0.7 https://www.moreblossom.com/trials/investigating-the-interaction-of-psilocybin-and-context-of-its-administration-in 2026-05-14T20:15:03Z monthly 0.7 https://www.moreblossom.com/trials/investigating-the-mechanisms-of-the-effects-of-psilocybin-on-visual-perception-a 2026-05-14T20:15:03Z monthly 0.7 https://www.moreblossom.com/trials/investigating-the-persisting-effects-of-a-single-dose-of-psilocybin-on-structura 2026-05-14T20:15:03Z monthly 0.7 https://www.moreblossom.com/trials/investigating-the-therapeutic-effects-of-psilocybin-in-treatment-resistant-post- 2026-05-07T16:11:34Z monthly 0.7 https://www.moreblossom.com/trials/investigation-of-antidepressant-efficacy-of-oral-ketamine-treatment 2026-03-24T14:47:10Z monthly 0.7 https://www.moreblossom.com/trials/investigation-of-psychedelic-effects-in-psychoactive-substances 2026-05-14T20:15:04Z monthly 0.7 https://www.moreblossom.com/trials/investigation-of-serotonin-neurotransmission-in-mdma-users-using-combinated-dexf 2026-05-07T16:05:26Z monthly 0.7 https://www.moreblossom.com/trials/investigation-of-the-antidepressant-effects-of-2r6r-hnk-an-enhancer-of-synaptic- 2026-05-14T20:15:04Z monthly 0.7 https://www.moreblossom.com/trials/investigation-to-understand-and-optimize-psilocybin-optimize 2026-05-14T20:15:04Z monthly 0.7 https://www.moreblossom.com/trials/iv-ketamine-vs-in-esketamine-for-mdd-trd 2026-05-07T16:15:27Z monthly 0.7 https://www.moreblossom.com/trials/kap-for-depression-in-abstinent-opioid-users-kredo 2026-05-14T20:15:04Z monthly 0.7 https://www.moreblossom.com/trials/ket-ro-plus-ro-dbt-for-treatment-resistant-depression-ket-ro 2026-05-14T20:15:05Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-alcohol-in-treatment-resistant-depression 2026-05-14T20:15:05Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-and-motivational-enhancement-therapy-for-the-treatment-of-tobacco-use-d 2026-05-14T20:15:05Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-and-neurofeedback-as-combined-therapeutic-interventions-to-target-gluta 2026-05-07T16:17:05Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-and-neurofeedback-training-effects-on-neuroplasticity-in-cocaine-addict 2026-05-07T16:14:15Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-and-nitroprusside-for-depression 2026-05-14T20:15:05Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-and-postoperative-depressive-symptom-passion 2026-05-07T16:07:36Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-and-scopolamine-infusions-for-treatment-resistant-major-depressive-diso 2026-05-14T20:15:06Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-and-stress-in-ocd 2026-05-07T16:12:38Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-anesthesia-for-improvement-of-depression-in-ect 2026-05-14T20:15:06Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-anesthesia-in-electroconvulsive-therapy 2026-05-14T20:15:06Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-as-a-rapid-treatment-for-post-traumatic-stress-disorder-ptsd 2026-05-14T20:15:07Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-as-a-rapidly-acting-antidepressant-in-depressed-emergency-department-pa 2026-05-14T20:15:07Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-as-an-adjunctive-therapy-for-major-depression-2-karma-dep2 2026-05-07T16:10:44Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-as-an-adjunctive-therapy-for-major-depression-karma-dep 2026-05-12T15:12:06Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-as-an-alternative-treatment-to-ect-in-major-depressive-disorder 2026-05-07T16:07:07Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-as-an-augmentation-strategy-for-electroconvulsive-therapy-ect-in-depres 2026-05-14T20:15:07Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-assisted-integrative-treatment-for-veterans-with-chronic-low-back-pain- 2026-05-14T20:15:07Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-assisted-mindfulness-based-cognitive-therapy-for-depression-a-pilot-stu 2026-05-14T20:15:08Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-assisted-psychological-therapy-to-reduce-alcohol-relapse 2026-05-07T16:18:52Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-assisted-psychotherapy-for-adolescent-ptsd-kap 2026-05-14T20:15:08Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-assisted-psychotherapy-for-methamphetamine-use-disorder 2026-05-07T18:37:47Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-assisted-psychotherapy-for-opioid-use-disorder 2026-05-14T20:15:08Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-assisted-psychotherapy-for-treating-comorbid-chronic-pain-and-ptsd 2026-05-07T16:17:10Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-assisted-psychotherapy-kap-compared-to-ketamine-alone-for-the-treatment 2026-05-14T20:15:08Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-assisted-psychotherapy-kap-for-patients-with-existential-distress-assoc 2026-05-14T20:15:08Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-assisted-psychotherapy-viability-in-treating-cancer-related-emotional-d 2026-05-07T16:11:52Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-associated-acc-gaba-and-glutamate-change-and-depression-remission 2026-05-14T20:15:09Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-augmentation-of-ect-in-treatment-resistant-depression-ketamina 2026-05-07T16:17:19Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-augmentation-of-ect-to-improve-outcomes-in-depression 2026-03-17T13:48:27Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-co-induction-for-patients-with-major-depressive-disorder 2026-05-07T16:08:17Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-cognitive-training-for-suicidality-in-the-medical-setting 2026-05-14T20:15:09Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-crisis-response-plan-for-suicidal-ideation-in-the-ed 2026-05-14T20:15:09Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-effects-on-learning-in-eating-disorders-kettle 2026-05-14T20:15:09Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-enhanced-prolonged-exposure-therapy-in-ptsd 2026-05-14T20:15:09Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-enhances-analgesia-and-mood-in-chronic-pain-patients 2026-05-07T16:13:45Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-combined-depression-and-alcohol-use-disorder-keda 2026-05-07T16:14:09Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-depression-an-mri-study 2026-05-14T20:15:10Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-depression-and-alcohol-dependence 2026-05-14T20:15:10Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-depression-and-suicide-risk 2026-05-14T20:15:10Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-depression-relapse-prevention-following-ect 2026-05-07T16:06:41Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-low-mood-states-in-the-er 2026-05-14T20:15:10Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-major-depressive-disorder 2026-05-14T20:15:10Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-methamphetamine-use-disorder-kmd 2026-05-14T20:15:11Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-mood-disorders-with-suicidal-ideation 2026-05-14T20:15:11Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-older-adults-pilot 2026-05-14T20:15:11Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-opioid-use-disorder 2026-05-14T20:15:11Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-oud-and-comorbid-depression-oudcd 2026-05-14T20:15:11Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-oud-and-suicidal-ideation-in-the-ed 2026-05-14T20:15:12Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-postherpetic-neuralgia-with-depression 2026-05-07T16:17:03Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-postoperative-avoidance-of-depressive-symptoms-the-k-pass-feasibili 2026-05-14T20:15:12Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-preventing-depression-in-patients-undergoing-treatment-for-pancreat 2026-05-14T20:15:12Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-reduction-of-alcoholic-relapse-kare 2026-05-12T15:23:09Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-relapse-prevention-in-recurrent-depressive-disorder 2026-05-07T16:07:08Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-sedation-in-severe-traumatic-brain-injury-ketamine 2026-05-14T20:15:12Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-severe-adolescent-depression-intermediate-term-safety-and-efficacy 2026-05-14T20:15:13Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-suicidal-ideation 2026-05-14T20:15:13Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-suicidality-in-bipolar-depression 2026-05-14T20:15:13Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-the-rapid-treatment-of-major-depressive-disorder-and-alcohol-use-di 2026-05-14T20:15:13Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-the-treatment-for-alcohol-use-disorder-in-the-ed 2026-05-14T20:15:14Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-the-treatment-of-depression-in-parkinsons-disease 2026-05-14T20:15:14Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-the-treatment-of-depression-with-anorexia-nervosa 2026-05-07T16:18:47Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-the-treatment-of-depressive-and-negative-symptoms-in-patients-with- 2026-03-17T13:49:03Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-the-treatment-of-opioid-use-disorder-and-depression 2026-05-14T20:15:14Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-treatment-resistant-bipolar-disorder 2026-05-07T16:10:52Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-treatment-resistant-depression-a-multicentric-clinical-trial-in-mex 2026-05-07T16:05:58Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-treatment-resistant-late-life-depression 2026-05-14T20:15:14Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-treatment-resistant-mdd 2026-05-07T16:08:42Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-for-veterans-with-parkinsons-disease-kpd 2026-05-14T20:15:14Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-frequency-treatment-for-major-depressive-disorder 2026-05-14T20:15:15Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-hcl-prolonged-release-oral-tablets-for-crps 2026-05-14T20:15:15Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-in-acute-brain-injury-patients 2026-05-07T16:11:06Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-in-adolescents-with-treatment-resistant-depression 2026-05-14T20:15:15Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-in-severe-traumatic-brain-injury 2026-05-14T20:15:15Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-in-the-treatment-of-depression 2026-05-14T20:15:15Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-in-the-treatment-of-suicidal-depression 2026-05-14T20:15:16Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-in-treatment-resistant-major-depression 2026-05-07T16:18:48Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-in-treatment-resistant-major-depression-trd 2026-03-24T14:47:39Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-infusion-for-adolescent-depression-and-anxiety 2026-05-14T20:15:16Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-infusion-for-rapid-reduction-of-suicidality-in-pediatrics-keta4si 2026-05-07T16:10:46Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-infusion-for-symptomatic-improvement-in-severe-borderline-personality-d 2026-05-07T16:17:21Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-infusion-for-treatment-resistant-major-depressive-disorder 2026-05-14T20:15:16Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-infusion-therapy-for-australian-veterans-with-treatment-resistant-depre 2026-05-07T18:35:58Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-infusion-therapy-for-the-treatment-of-ptsd-in-paramedics 2026-05-14T20:15:16Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-infusions-for-major-depression-disorder 2026-05-07T16:06:29Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-infusions-for-ptsd-and-treatment-resistant-depression 2026-05-14T20:15:16Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-interleaved-with-electroconvulsive-therapy-for-depression 2026-05-07T16:08:51Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-iv-classic-protocol-five-years-follow-up 2026-05-07T16:10:22Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-long-therm-follow-up-study 2026-05-07T16:09:09Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-low-dose-evaluation-on-morphine-consumption-in-traumatic-patient-kloe 2026-05-07T16:10:24Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-magnesium-for-chronic-cluster-headache-ketalgia 2026-05-07T16:10:20Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-mindfulness-for-depression 2026-05-14T20:15:17Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-or-placebo-in-patients-with-major-depression-and-advanced-cancer 2026-05-07T16:09:35Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-pharmacokinetics-and-pharmacodynamics-for-postpartum-depression-and-pai 2026-05-14T20:15:17Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-plus-exposure-therapy-for-post-traumatic-stress-disorder-ptsd-open-labe 2026-05-07T18:45:08Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-plus-lithium-in-treatment-resistant-depression 2026-05-14T20:15:17Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-sgb-and-combination-treatment-for-tbi 2026-05-14T20:15:17Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-therapy-experiential-education-study 2026-05-07T16:12:13Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-therapy-for-methamphetamine-use-disorder-hiv-ketamet 2026-05-14T20:15:17Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-to-prevent-ppd-after-cesarean 2026-05-14T20:15:18Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-to-treat-patients-with-post-comatose-disorders-of-consciousness 2026-05-07T16:11:51Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-treatment-effects-on-synaptic-plasticity-in-depression 2026-05-14T20:15:18Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-treatment-for-ptsd-and-mdd-in-tbi 2026-05-14T20:15:18Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-treatment-of-youth-suicide-attempters 2026-05-14T20:15:18Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-treatment-plans-for-chronic-conditions 2026-05-14T20:15:18Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-trial-for-the-treatment-of-depression 2026-05-07T16:06:40Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-use-in-electroconvulsive-therapy 2026-05-07T16:06:12Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-versus-electroconvulsive-therapy-in-depression 2026-05-07T16:08:18Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-versus-ketamine-plus-behavioural-activation-therapy-for-adults-with-tre 2026-05-07T18:35:41Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-versus-midazolam-for-recurrence-of-suicidality-in-adolescents 2026-05-14T20:15:19Z monthly 0.7 https://www.moreblossom.com/trials/ketamine-versus-placebo-for-treatment-resistant-major-depressive-disorder 2026-05-14T20:15:19Z monthly 0.7 https://www.moreblossom.com/trials/ketamines-actions-on-rumination-mechanisms-as-an-antidepressant 2026-05-07T16:09:59Z monthly 0.7 https://www.moreblossom.com/trials/kf20241-trial-esketamine-interaction-study 2026-05-07T16:16:09Z monthly 0.7 https://www.moreblossom.com/trials/long-term-follow-up-ket-pd 2026-05-14T20:15:19Z monthly 0.7 https://www.moreblossom.com/trials/long-term-follow-up-study-to-comp-001-and-comp-003-trials-p-trd-ltfu 2026-05-14T20:15:19Z monthly 0.7 https://www.moreblossom.com/trials/long-term-maintenance-with-ketamine-and-esketamine-for-reduction-of-suicide-in-h 2026-05-14T20:15:19Z monthly 0.7 https://www.moreblossom.com/trials/long-term-observation-of-participants-with-mood-disorders 2026-05-14T20:15:20Z monthly 0.7 https://www.moreblossom.com/trials/long-term-safety-and-effectiveness-of-manualized-mdma-assisted-therapy-for-the-t 2026-05-14T20:15:20Z monthly 0.7 https://www.moreblossom.com/trials/long-term-safety-and-persistence-of-effectiveness-of-manualized-mdma-assisted-th 2025-11-08T00:10:55Z monthly 0.7 https://www.moreblossom.com/trials/low-dose-intravenous-ketamine-for-adolescents-with-depression-and-suicidal-ideat 2026-05-14T20:15:20Z monthly 0.7 https://www.moreblossom.com/trials/low-dose-intravenous-ketamine-in-treatment-resistant-depression-patients 2026-05-14T20:15:20Z monthly 0.7 https://www.moreblossom.com/trials/low-dose-ketamine-and-postpartum-depression-in-parturients-with-prenatal-depress 2026-05-07T16:07:53Z monthly 0.7 https://www.moreblossom.com/trials/low-dose-ketamine-infusion-among-adolescents-with-treatment-resistant-depression 2026-05-07T16:10:58Z monthly 0.7 https://www.moreblossom.com/trials/low-dose-ketamine-infusion-for-the-treatment-of-resistant-depression 2026-05-14T20:15:20Z monthly 0.7 https://www.moreblossom.com/trials/low-dose-s-ketamine-and-postpartum-depression-in-parturients-with-prenatal-depre 2026-05-07T16:08:35Z monthly 0.7 https://www.moreblossom.com/trials/low-dose-s-ketamine-in-women-with-prenatal-depression 2026-05-07T16:09:26Z monthly 0.7 https://www.moreblossom.com/trials/low-income-group-psilocybin-assisted-therapy-for-depression-ligpatd 2026-05-14T20:15:20Z monthly 0.7 https://www.moreblossom.com/trials/lsd-base-and-lsd-tartrate-bioequivalence-and-bioavailability-in-healthy-subjects 2026-05-07T16:10:34Z monthly 0.7 https://www.moreblossom.com/trials/lsd-microdosing 2026-03-17T13:50:12Z monthly 0.7 https://www.moreblossom.com/trials/lsd-microdosing-a-repeated-dosing-study 2026-03-17T13:50:13Z monthly 0.7 https://www.moreblossom.com/trials/lsd-occupancy-of-the-serotonin-2a-receptor-in-the-human-brain-doccls 2026-05-07T16:13:37Z monthly 0.7 https://www.moreblossom.com/trials/lsd-perceptual-choice-study-lucy 2026-05-07T16:13:42Z monthly 0.7 https://www.moreblossom.com/trials/lsd-therapy-for-persons-suffering-from-major-depression 2026-05-13T10:16:20Z monthly 0.7 https://www.moreblossom.com/trials/lsd-to-improve-cluster-headache-impact-trial 2026-05-07T16:12:16Z monthly 0.7 https://www.moreblossom.com/trials/lsd-treatment-for-persons-with-alcohol-use-disorder-lysta 2026-05-07T16:12:15Z monthly 0.7 https://www.moreblossom.com/trials/lsd-treatment-in-persons-suffering-from-anxiety-symptoms-in-severe-somatic-disea 2026-05-07T16:07:40Z monthly 0.7 https://www.moreblossom.com/trials/lucid-201-001-a-double-blind-single-ascending-dose-study-to-assess-the-safety-ph 2026-05-07T18:35:38Z monthly 0.7 https://www.moreblossom.com/trials/lysergic-acid-diethylamide-lsd-as-treatment-for-cluster-headache 2026-05-07T16:08:25Z monthly 0.7 https://www.moreblossom.com/trials/lysergic-acid-diethylamide-lsd-assisted-psychotherapy-in-people-with-illness-rel 2026-05-07T16:05:09Z monthly 0.7 https://www.moreblossom.com/trials/lysergic-acid-diethylamide-lsd-in-palliative-care-lpc 2026-05-07T16:13:28Z monthly 0.7 https://www.moreblossom.com/trials/maintenance-ketamine-infusions-for-treatment-resistant-bipolar-depression 2026-05-07T16:11:50Z monthly 0.7 https://www.moreblossom.com/trials/mdma-34-methylenedioxy-n-methylamphetamine-for-the-treatment-of-tinnitus 2026-05-07T18:36:28Z monthly 0.7 https://www.moreblossom.com/trials/mdma-and-memory 2026-04-27T13:46:20Z monthly 0.7 https://www.moreblossom.com/trials/mdma-and-prosocial-behavior 2026-03-17T13:50:29Z monthly 0.7 https://www.moreblossom.com/trials/mdma-and-prosocial-behavior-the-role-of-the-2a-serotonin-receptor 2026-03-17T13:50:30Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-brief-cognitive-behavioral-conjoint-therapy-for-ptsd-mdma-bcbct 2026-05-14T20:15:21Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-cbct-for-ptsd-vs-cbct-rct 2026-05-07T16:13:58Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-cbt-for-ocd-mdma-cbt4ocd 2026-05-14T20:15:21Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-cognitive-behavioral-conjoint-therapy-cbct-in-dyads-in-which-1-mem 2026-05-14T20:15:21Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-massed-prolonged-exposure-for-ptsd 2026-05-14T20:15:22Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-prolonged-exposure-therapy-for-comorbid-alcohol-use-disorder-and-p 2026-05-07T16:13:00Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-psychotherapy-for-anxiety-associated-with-a-life-threatening-illne 2026-05-19T08:55:38Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-psychotherapy-for-treatment-resistant-ptsd-in-adolescents 2026-05-14T20:15:22Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-psychotherapy-in-veterans-with-combat-related-refractory-ptsd 2026-05-14T20:15:22Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-therapy-for-adjustment-disorder-ad-in-dyads-of-patients-with-cance 2026-05-14T20:15:22Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-therapy-for-fibromyalgia 2026-05-14T20:15:23Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-therapy-for-mental-healthcare-providers 2026-05-14T20:15:23Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-therapy-for-pathological-narcissism 2026-05-14T20:15:23Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-therapy-for-stress-disorders-in-healthcare-workers 2026-05-14T20:15:23Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-therapy-for-veterans-with-moderate-to-severe-post-traumatic-stress 2026-05-14T20:15:23Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-therapy-in-people-with-anxiety-related-to-advanced-stage-cancer 2026-05-14T20:15:24Z monthly 0.7 https://www.moreblossom.com/trials/mdma-assisted-therapy-versus-cognitive-processing-therapy-for-veterans-with-seve 2026-05-14T20:15:24Z monthly 0.7 https://www.moreblossom.com/trials/mdma-cortisol-and-memory 2026-03-17T13:50:51Z monthly 0.7 https://www.moreblossom.com/trials/mdma-for-aud-ptsd-comorbidity-mdma 2026-05-14T20:15:24Z monthly 0.7 https://www.moreblossom.com/trials/mdma-for-co-occurring-ptsd-and-oud-after-childbirth 2026-05-14T20:15:24Z monthly 0.7 https://www.moreblossom.com/trials/mdma-in-borderline-personality-disorder-mdma-in-bpd 2026-05-14T20:15:24Z monthly 0.7 https://www.moreblossom.com/trials/mdma-in-subjects-with-moderate-hepatic-impairment-and-subjects-with-normal-hepat 2026-05-14T20:15:25Z monthly 0.7 https://www.moreblossom.com/trials/mdma-plus-exposure-therapy-for-ptsd 2026-05-14T20:15:25Z monthly 0.7 https://www.moreblossom.com/trials/mechanism-of-action-underlying-ketamines-antidepressant-effects-the-ampa-through 2026-05-14T20:15:25Z monthly 0.7 https://www.moreblossom.com/trials/mechanistic-studies-of-psilocybin-in-headache-disorders 2026-05-14T20:15:25Z monthly 0.7 https://www.moreblossom.com/trials/metabolic-profiling-of-esketamine-treatment-in-depressive-disorder 2026-05-07T16:17:09Z monthly 0.7 https://www.moreblossom.com/trials/methamphetamine-use-in-young-people-safety-and-tolerability-of-sub-anaesthetic-k 2026-05-07T18:35:23Z monthly 0.7 https://www.moreblossom.com/trials/methylenedioxymethamphetamine-mdma-ecstasy-induced-changes-in-drug-metabolism-ge 2026-05-07T16:05:33Z monthly 0.7 https://www.moreblossom.com/trials/micro-dose-macro-impact-leveraging-psychedelics-in-frontline-healthcare-workers- 2026-05-14T20:15:25Z monthly 0.7 https://www.moreblossom.com/trials/microdosing-psychedelics-to-improve-mood 2026-05-07T16:11:36Z monthly 0.7 https://www.moreblossom.com/trials/mindfulness-and-psychedelics 2026-05-07T16:13:10Z monthly 0.7 https://www.moreblossom.com/trials/mindfulness-assisted-psychedelic-therapy-mapt 2026-05-14T20:15:26Z monthly 0.7 https://www.moreblossom.com/trials/mindfulness-based-psilocybin-therapy-for-ptsd 2026-05-07T16:17:23Z monthly 0.7 https://www.moreblossom.com/trials/mirnas-suicide-and-ketamine-plasma-exosomal-micrornas-as-novel-biomarkers-for-su 2026-05-14T20:15:26Z monthly 0.7 https://www.moreblossom.com/trials/modified-ketogenic-diet-and-ketamine-for-anorexia-nervosa 2026-05-14T20:15:26Z monthly 0.7 https://www.moreblossom.com/trials/molecular-imaging-study-of-harmine-dmt-a-basic-research-approach-had-pet 2026-05-07T16:14:41Z monthly 0.7 https://www.moreblossom.com/trials/mood-and-cognitive-effects-of-psilocybin-in-healthy-participants-melo 2026-05-07T16:11:36Z monthly 0.7 https://www.moreblossom.com/trials/mood-effects-of-serotonin-agonists 2026-05-14T20:15:26Z monthly 0.7 https://www.moreblossom.com/trials/mood-effects-of-serotonin-agonists-extended 2026-05-14T20:15:26Z monthly 0.7 https://www.moreblossom.com/trials/multi-center-rct-of-iv-ketamine-efficacy-and-safety-in-chronic-daily-headaches 2026-05-07T16:11:43Z monthly 0.7 https://www.moreblossom.com/trials/music-as-an-adjunct-to-ketamine-therapy-for-chronic-pain-muskip 2026-05-07T16:17:08Z monthly 0.7 https://www.moreblossom.com/trials/music-as-an-intervention-to-improve-hemodynamic-tolerability-of-ketamine-in-depr 2026-05-07T16:10:07Z monthly 0.7 https://www.moreblossom.com/trials/n-methyl-d-aspartate-antagonist-ketamine-augmentation-of-electroconvulsive-treat 2026-05-14T20:15:27Z monthly 0.7 https://www.moreblossom.com/trials/naltrexone-plus-ketamine-for-the-rapid-treatment-of-major-depressive-disorder-an 2026-05-07T16:08:15Z monthly 0.7 https://www.moreblossom.com/trials/naturalistic-study-into-the-hangover-effects-of-mdma 2026-03-17T13:51:21Z monthly 0.7 https://www.moreblossom.com/trials/naturalistic-study-of-ketamine-in-the-treatment-of-depression 2026-05-07T16:11:35Z monthly 0.7 https://www.moreblossom.com/trials/naturalistic-study-of-microdosing-with-psilocybin-natmicro 2026-05-07T16:11:14Z monthly 0.7 https://www.moreblossom.com/trials/nebulized-ketamine-for-the-treatment-of-major-depressive-disorder-in-an-inpatien 2026-05-14T20:15:27Z monthly 0.7 https://www.moreblossom.com/trials/neural-and-physiological-correlates-of-psychedelic-sub-states-i2 2026-05-14T20:15:27Z monthly 0.7 https://www.moreblossom.com/trials/neural-circuit-effects-of-ketamine-in-depression 2026-05-14T20:15:27Z monthly 0.7 https://www.moreblossom.com/trials/neural-correlates-of-ketamines-anti-suicidal-effects-in-bipolar-depression-deepp 2026-05-07T16:11:19Z monthly 0.7 https://www.moreblossom.com/trials/neurobehavioral-mechanisms-of-psilocybin-assisted-treatment-for-aud 2026-05-14T20:15:27Z monthly 0.7 https://www.moreblossom.com/trials/neurobiological-effects-of-psilocybin-in-treatment-resistant-bipolar-depression- 2026-05-07T16:15:28Z monthly 0.7 https://www.moreblossom.com/trials/neurobiology-and-pharmacokinets-of-acute-mdma-administration 2026-05-14T20:15:28Z monthly 0.7 https://www.moreblossom.com/trials/neurodynamics-of-prosocial-emotional-processing-following-serotonergic-stimulati 2026-05-07T16:10:11Z monthly 0.7 https://www.moreblossom.com/trials/neuromodulation-to-facilitate-the-effect-of-ketamine 2026-05-14T20:15:28Z monthly 0.7 https://www.moreblossom.com/trials/neuronal-correlates-of-altered-states-of-consciousness-5ht2a-fmri 2026-05-07T16:06:37Z monthly 0.7 https://www.moreblossom.com/trials/neuropharmacologic-imaging-and-biomarker-assessments-of-response-to-acute-and-re 2026-05-14T20:15:28Z monthly 0.7 https://www.moreblossom.com/trials/nitrous-oxide-as-treatment-for-major-depression-a-pilot-study 2026-05-14T20:15:28Z monthly 0.7 https://www.moreblossom.com/trials/nitrous-oxide-for-the-treatment-of-major-depressive-disorder 2026-05-14T20:15:28Z monthly 0.7 https://www.moreblossom.com/trials/nmda-antagonists-in-bipolar-depression 2026-05-14T20:15:29Z monthly 0.7 https://www.moreblossom.com/trials/northwest-therapies-trauma-psilocybin-study-compassionate-use-study 2026-05-14T20:15:29Z monthly 0.7 https://www.moreblossom.com/trials/nrx-101-for-maintenance-of-remission-from-severe-bipolar-depression-in-patients- 2026-05-14T20:15:29Z monthly 0.7 https://www.moreblossom.com/trials/nrx100-vs-placebo-for-rapid-stabilization-of-acute-suicidal-ideation-and-behavio 2026-05-14T20:15:29Z monthly 0.7 https://www.moreblossom.com/trials/observation-of-ketamine-treatment-safety-and-tolerability-in-adult-psychiatry-cl 2026-05-07T16:12:34Z monthly 0.7 https://www.moreblossom.com/trials/observation-of-safety-and-tolerability-within-1-year-of-the-use-of-r-ketamine-pl 2026-05-07T16:14:37Z monthly 0.7 https://www.moreblossom.com/trials/oktop-open-label-oral-ketamine-ptsd 2026-05-12T05:41:09Z monthly 0.7 https://www.moreblossom.com/trials/open-label-dose-ranging-study-of-oral-sm-001-in-healthy-adults 2026-05-14T20:15:29Z monthly 0.7 https://www.moreblossom.com/trials/open-label-ketamine-treatment-for-major-depressive-disorder-in-veterans 2026-05-14T20:15:30Z monthly 0.7 https://www.moreblossom.com/trials/open-label-multi-site-study-of-safety-and-effects-of-mdma-assisted-fmri 2026-05-07T16:08:43Z monthly 0.7 https://www.moreblossom.com/trials/open-label-multi-site-study-of-safety-and-effects-of-mdma-assisted-psychotherapy 2026-05-14T20:15:30Z monthly 0.7 https://www.moreblossom.com/trials/open-label-proof-of-concept-feasibility-study-to-explore-the-safety-tolerability 2026-03-24T14:48:22Z monthly 0.7 https://www.moreblossom.com/trials/open-label-psilocybin 2026-05-14T20:15:30Z monthly 0.7 https://www.moreblossom.com/trials/open-label-study-to-assess-the-safety-and-efficacy-of-trp-8802-with-psychotherap 2026-05-14T20:15:30Z monthly 0.7 https://www.moreblossom.com/trials/open-study-of-the-neurobiological-effects-of-intranasal-ketamine-in-children-and 2026-05-14T20:15:30Z monthly 0.7 https://www.moreblossom.com/trials/opiate-suicide-study-in-patients-with-major-depression 2026-05-14T20:15:31Z monthly 0.7 https://www.moreblossom.com/trials/optimization-of-iv-ketamine-for-treatment-resistant-depression 2026-05-14T20:15:31Z monthly 0.7 https://www.moreblossom.com/trials/optimizing-microdosing-and-meditation-omm-2 2026-05-14T20:15:31Z monthly 0.7 https://www.moreblossom.com/trials/oral-aspirin-ketamine-as-adjunct-to-oral-antidepressant-therapy-for-depression 2026-05-14T20:15:31Z monthly 0.7 https://www.moreblossom.com/trials/oral-ketamine-as-an-additional-treatment-in-patients-with-treatment-resistant-de 2026-05-11T19:32:00Z monthly 0.7 https://www.moreblossom.com/trials/oral-ketamine-in-the-treatment-of-depression-and-anxiety-in-patients-with-cancer 2026-05-14T20:15:31Z monthly 0.7 https://www.moreblossom.com/trials/oral-ketamine-trial-on-people-aged-16-years-and-older-with-treatment-resistant-depression 2026-05-07T18:35:22Z monthly 0.7 https://www.moreblossom.com/trials/outpatient-buprenorphine-induction-with-psilocybin-for-opioid-use-disorder 2026-05-14T20:15:32Z monthly 0.7 https://www.moreblossom.com/trials/pairing-psilocybin-with-transauricular-vagus-nerve-stimulation-enhance 2026-05-14T20:15:32Z monthly 0.7 https://www.moreblossom.com/trials/palliadelic-treatment-to-reduce-psychological-distress-in-persons-with-inoperabl 2026-05-14T20:15:32Z monthly 0.7 https://www.moreblossom.com/trials/papaya-pharmacologically-assisted-psychotherapy-for-social-anxiety-in-young-peop 2026-05-07T18:35:59Z monthly 0.7 https://www.moreblossom.com/trials/papr-pap-mbsr-for-front-line-healthcare-provider-covid-19-related-burnout-papr 2026-05-14T20:15:32Z monthly 0.7 https://www.moreblossom.com/trials/parting-psilocybin-assisted-supportive-psychotherapy-in-the-treatment-of-prolong 2026-05-07T18:43:23Z monthly 0.7 https://www.moreblossom.com/trials/pcori-comparative-effectiveness-study-esketamine-spravato-vs-ketamine-equivalenc 2026-05-14T20:15:32Z monthly 0.7 https://www.moreblossom.com/trials/perceptions-of-mdma-assisted-therapy-among-veterans-with-ptsd 2026-05-14T20:15:33Z monthly 0.7 https://www.moreblossom.com/trials/perioperative-ketamine-in-opioid-tolerant-patients-undergoing-lumbar-spine-surge 2026-05-14T20:15:33Z monthly 0.7 https://www.moreblossom.com/trials/persisting-effects-of-psilocybin 2026-05-14T20:15:33Z monthly 0.7 https://www.moreblossom.com/trials/personality-and-drug-use-pdu 2026-05-07T16:12:23Z monthly 0.7 https://www.moreblossom.com/trials/pet-imaging-of-mglur5-with-drug-challenge 2026-05-14T20:15:33Z monthly 0.7 https://www.moreblossom.com/trials/pet-synaptogenesis-after-psilocybin-in-depression-recovery-pet-spider 2026-05-14T20:15:33Z monthly 0.7 https://www.moreblossom.com/trials/pex010-assisted-therapy-for-stimulant-use-disorder-a-safety-feasibility-and-effi 2026-05-07T16:15:59Z monthly 0.7 https://www.moreblossom.com/trials/pharmacogenetics-associated-with-iv-ketamine 2026-05-07T16:10:04Z monthly 0.7 https://www.moreblossom.com/trials/pharmacokinetic-pharmacodynamic-modeling-of-s-ketamine-in-healthy-volunteers 2026-03-17T13:52:15Z monthly 0.7 https://www.moreblossom.com/trials/pharmacokinetics-of-gh001-in-healthy-volunteers 2026-05-07T16:11:16Z monthly 0.7 https://www.moreblossom.com/trials/pharmacokinetics-safety-and-tolerability-of-intramuscular-5-meo-dmt-in-healthy-v 2026-05-14T20:15:34Z monthly 0.7 https://www.moreblossom.com/trials/pharmacologic-treatment-augmentation-in-chronic-depression-ketcbasp 2026-05-07T16:15:10Z monthly 0.7 https://www.moreblossom.com/trials/pharmacologic-treatment-augmentation-in-chronic-depressionrandomized-controlled- 2026-03-24T14:48:32Z monthly 0.7 https://www.moreblossom.com/trials/pharmacological-interaction-between-carvedilol-and-methylenedioxymethamphetamine 2026-05-07T16:05:25Z monthly 0.7 https://www.moreblossom.com/trials/pharmacological-interaction-between-clonidine-and-methylenedioxymethamphetamine- 2026-05-07T16:05:18Z monthly 0.7 https://www.moreblossom.com/trials/pharmacological-interaction-between-doxazosin-and-methylenedioxymethamphetamine- 2026-05-07T16:05:30Z monthly 0.7 https://www.moreblossom.com/trials/pharmacological-interaction-between-pindolol-and-mdma-34-methylenedioxymethamphe 2026-05-07T16:05:08Z monthly 0.7 https://www.moreblossom.com/trials/pharmacology-of-human-decision-making-study-of-the-effects-of-ketamine-on-health 2026-05-07T18:44:41Z monthly 0.7 https://www.moreblossom.com/trials/phase-1-bioavailability-study-of-melt-100-midazolam-and-ketamine-sublingual-and- 2026-05-14T20:15:34Z monthly 0.7 https://www.moreblossom.com/trials/phase-1-evaluation-of-2r6r-hydroxynorketamine 2026-05-14T20:15:34Z monthly 0.7 https://www.moreblossom.com/trials/phase-1b-study-in-patients-with-short-lasting-unilateral-neuralgiform-headache-a 2026-05-12T19:39:56Z monthly 0.7 https://www.moreblossom.com/trials/phase-2-clinical-trial-of-gh001-in-bipolar-ii-disorder 2026-05-07T16:13:22Z monthly 0.7 https://www.moreblossom.com/trials/phase-2-clinical-trial-of-gh001-in-postpartum-depression 2026-05-07T16:13:17Z monthly 0.7 https://www.moreblossom.com/trials/phase-2-pilot-safety-study-of-mdma-assisted-therapy-for-social-anist 2026-05-14T20:15:34Z monthly 0.7 https://www.moreblossom.com/trials/phase-i-open-label-study-of-low-dose-ketamine-infusion-treatment-in-levodopa-ind 2026-05-14T20:15:34Z monthly 0.7 https://www.moreblossom.com/trials/phase-i-psilocybin-safety-trial-atma 2026-05-07T16:18:45Z monthly 0.7 https://www.moreblossom.com/trials/phase-iii-long-term-extension-trial-to-assess-safety-and-efficacy-of-cyb003-in-m 2026-05-14T20:15:35Z monthly 0.7 https://www.moreblossom.com/trials/phenomenological-explorations-of-the-esketamine-induced-transient-dissociative-s 2026-05-07T16:14:18Z monthly 0.7 https://www.moreblossom.com/trials/physiological-and-cognitive-biomarkers-for-ketamines-antidepressant-effects 2026-05-14T20:15:35Z monthly 0.7 https://www.moreblossom.com/trials/pilot-investigation-of-psychedelic-assisted-psychotherapy-for-treatment-of-post- 2026-05-07T18:44:38Z monthly 0.7 https://www.moreblossom.com/trials/pilot-recap-study-in-healthy-normal-volunteers 2026-05-14T20:15:35Z monthly 0.7 https://www.moreblossom.com/trials/pilot-study-effects-of-psilocybin-on-behavior-psychology-and-brain-function-in-l 2026-05-14T20:15:35Z monthly 0.7 https://www.moreblossom.com/trials/pilot-study-establishing-glutamatergic-changes-in-rapid-antidepressant-effects-o 2026-05-07T16:16:22Z monthly 0.7 https://www.moreblossom.com/trials/pilot-study-evaluating-the-efficacy-of-subcutaneous-ketamine-for-the-treatment-o 2026-05-07T18:40:53Z monthly 0.7 https://www.moreblossom.com/trials/pilot-study-for-the-rapid-alleviation-of-depression-in-depressed-alcohol-depende 2026-05-07T18:35:06Z monthly 0.7 https://www.moreblossom.com/trials/pilot-study-of-administration-of-psilocybin-in-healthy-volunteers-within-a-marae 2026-05-07T18:35:52Z monthly 0.7 https://www.moreblossom.com/trials/pilot-study-of-psilocybin-assisted-therapy-for-demoralization-in-patients-receiv 2026-05-14T20:15:35Z monthly 0.7 https://www.moreblossom.com/trials/pilot-study-of-rr-hnk-in-ocd-hnko 2026-05-14T20:15:36Z monthly 0.7 https://www.moreblossom.com/trials/pilot-study-on-the-effects-of-ketamine-on-mood-and-eating-disorder-cognitions-in 2026-05-07T18:35:13Z monthly 0.7 https://www.moreblossom.com/trials/pilot-trial-of-visual-healing-in-psilocybin-assisted-therapy-for-alcohol-use-dis 2026-05-14T20:15:36Z monthly 0.7 https://www.moreblossom.com/trials/placebo-controlled-study-of-sublingual-salvinorin-a 2026-05-07T16:05:20Z monthly 0.7 https://www.moreblossom.com/trials/plasma-oxytocin-changes-in-response-to-low-dose-mdma-vs-placebo-in-patients-with 2026-05-07T16:16:23Z monthly 0.7 https://www.moreblossom.com/trials/positioning-of-esketamine-treatment-in-the-real-world-management-of-depression 2026-05-07T16:14:12Z monthly 0.7 https://www.moreblossom.com/trials/positron-emission-tomography-assessment-of-ketamine-binding-of-the-serotonin-tra 2026-05-07T16:07:10Z monthly 0.7 https://www.moreblossom.com/trials/pragmatic-trial-of-psilocybin-therapy-in-palliative-care-pt2pc 2026-05-14T20:15:36Z monthly 0.7 https://www.moreblossom.com/trials/pre-post-evaluation-of-the-safety-and-efficacy-of-ibogaine-magnesium-therapy-in- 2026-05-14T20:15:36Z monthly 0.7 https://www.moreblossom.com/trials/precision-functional-brain-mapping-in-psilocybin 2026-05-14T20:15:36Z monthly 0.7 https://www.moreblossom.com/trials/prediction-of-response-to-depression-interventions-using-clinical-and-td-fnirs-m 2026-05-14T20:15:37Z monthly 0.7 https://www.moreblossom.com/trials/predictors-of-intravenous-ketamine-response-in-trd 2026-05-07T16:12:47Z monthly 0.7 https://www.moreblossom.com/trials/preliminary-effectiveness-of-individual-and-group-mdma-assisted-therapy-for-isra 2026-05-07T16:13:04Z monthly 0.7 https://www.moreblossom.com/trials/preliminary-efficacy-and-safety-of-ibogaine-in-the-treatment-of-methadone-detoxi 2026-05-07T16:08:40Z monthly 0.7 https://www.moreblossom.com/trials/preoperative-ketamine-and-perioperative-depression 2026-05-07T16:09:04Z monthly 0.7 https://www.moreblossom.com/trials/proof-of-concept-study-evaluating-the-efficacy-and-safety-of-mij821-in-patients- 2026-05-14T20:15:37Z monthly 0.7 https://www.moreblossom.com/trials/proof-of-concept-study-for-evaluation-of-the-effect-of-ketamine-intranasal-spray 2026-05-12T09:55:23Z monthly 0.7 https://www.moreblossom.com/trials/prophylactic-effects-of-psilocybin-on-chronic-cluster-headache 2026-05-12T23:28:20Z monthly 0.7 https://www.moreblossom.com/trials/prosocial-effects-of-mdma-pem 2026-05-14T20:15:37Z monthly 0.7 https://www.moreblossom.com/trials/psil201-long-term-follow-up-study-psilocybin-or-niacin-major-depressive-disorder 2026-05-14T20:15:37Z monthly 0.7 https://www.moreblossom.com/trials/psilocd-a-pharmacological-challenge-feasibility-study 2026-05-13T05:22:42Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-a-strategy-of-rapid-antidepressant-response-in-depression-comorbid-wi 2026-03-24T14:48:48Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-and-depression 2026-05-07T16:07:56Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-and-methylenedioxymethamphetamine-mdma-for-post-traumatic-stress-diso 2026-05-14T20:15:38Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-and-spiritual-practice 2026-05-14T20:15:38Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-as-a-tool-for-enhancing-cognitive-flexibility-2 2026-03-17T13:53:13Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-as-a-treatment-for-anorexia-nervosa-a-pilot-study 2026-05-07T16:09:40Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-cbt-for-depression 2026-05-14T20:15:38Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-cognitive-processing-therapy-for-chronic-ptsd 2026-05-07T16:15:03Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-existential-attachment-and-relational-pearl-therapy-for-care 2026-05-07T16:17:11Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-existential-attachment-and-relational-pearl-therapy-for-pati 2026-05-07T16:15:11Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-group-therapy-for-demoralization-in-long-term-aids-survivors 2026-05-14T20:15:38Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-interpersonal-and-social-rhythm-therapy-for-depression 2026-05-07T16:12:38Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-psychotherapy-for-alcohol-use-disorder-pap-aud 2026-05-07T16:13:46Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-psychotherapy-for-anxiety-in-people-with-stage-iv-melanoma 2026-05-14T20:15:38Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-psychotherapy-for-the-treatment-of-depression-and-anxiety-as 2026-05-13T03:03:14Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-psychotherapy-for-treatment-resistant-depression-comparing-o 2026-05-07T16:14:50Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-psychotherapy-in-cancer-patients-with-adjustment-disorder 2026-05-07T16:17:16Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-psychotherapy-in-patients-with-advanced-cancer-on-maintenanc 2026-05-14T20:15:39Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-psychotherapy-in-treating-irritable-bowel-syndrome-ibs 2026-05-14T20:15:39Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-for-alcohol-use-disorder 2026-05-07T16:15:20Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-for-intergenerational-trauma 2026-05-14T20:15:39Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-for-phantom-limb-pain 2026-05-14T20:15:39Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-for-physician-well-being-and-burnout 2026-05-14T20:15:39Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-for-post-traumatic-stress-disorder-in-survivors-of-i 2026-05-07T16:16:46Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-for-severe-alcohol-use-disorder 2026-05-07T16:14:22Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-for-sexual-assault-related-ptsd-sun004 2026-05-14T20:15:40Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-for-the-treatment-of-cancer-related-anxiety-in-patie 2026-05-14T20:15:40Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-for-treatment-of-alcohol-use-disorder 2026-05-07T16:12:05Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-for-treatment-resistant-depression-in-bipolar-ii-dis 2026-05-07T16:16:59Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-therapy-in-treatment-resistant-depression 2026-05-14T20:15:40Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-treatment-for-cannabis-use-disorder 2026-05-14T20:15:40Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-assisted-vs-ketamine-assisted-psychotherapy-for-alcohol-use-disorder 2026-05-14T20:15:40Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-brain-stimulation-and-imaging-pilot-study-opte 2026-05-14T20:15:41Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-cancer-anxiety-study 2026-05-14T20:15:41Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-combined-with-multidisciplinary-palliative-care-in-demoralized-cancer 2026-05-14T20:15:41Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-enhanced-psychotherapy-for-methamphetamine-use-disorder 2026-05-14T20:15:41Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-facilitated-smoking-cessation-treatment-a-pilot-study 2026-05-14T20:15:42Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-facilitated-treatment-for-chronic-pain 2026-05-14T20:15:42Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-facilitated-treatment-for-cocaine-use 2026-05-14T20:15:42Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-chronic-pelvic-pain-cpp-in-women-a-pilot-feasibility-study 2026-05-14T20:15:42Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-depression 2026-05-12T17:36:14Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-depression-in-people-with-mild-cognitive-impairment-or-early-alzh 2026-05-14T20:15:43Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-enhanced-analgesia-in-chronic-neuropathic-pain-peace-pain 2026-05-07T16:16:10Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-hospitalized-patients-with-treatment-resistant-depression-psihos- 2026-05-07T16:15:01Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-major-depressive-disorder-mdd-uaspire 2026-05-14T20:15:43Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-methamphetamine-addiction 2026-05-14T20:15:43Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-opioid-use-disorder-in-patients-on-methadone-maintenance-with-ong 2026-05-12T23:18:33Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-opioid-use-disorder-oud 2026-05-14T20:15:43Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-prolonged-grief-disorder 2026-05-14T20:15:43Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-psychological-and-existential-distress-in-palliative-care 2026-05-07T16:10:14Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-the-treatment-of-cluster-headache 2026-05-14T20:15:44Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-the-treatment-of-migraine-headache 2026-05-14T20:15:44Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-the-treatment-of-veterans-with-post-traumatic-stress-disorder 2026-05-14T20:15:44Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-treatment-of-alcohol-use-disorder-a-feasibility-study 2026-05-07T16:10:12Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-treatment-of-obsessive-compulsive-disorder 2026-05-14T20:15:44Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-treatment-of-ocd-2 2026-05-14T20:15:44Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-treatment-resistant-depression 2026-05-12T23:06:39Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-treatment-resistant-depression-2 2026-05-14T20:15:45Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-for-treatment-resistant-depression-in-autism-with-pre-post-brain-and- 2026-05-07T16:16:11Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-in-adults-with-and-without-autism-spectrum-disorder-psilaut 2026-05-07T16:12:50Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-in-alcohol-use-disorder-with-comorbid-depression-pad 2026-05-13T04:15:27Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-in-cancer-pain-study 2026-05-14T20:15:45Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-in-chronic-low-back-pain-and-depression 2026-05-14T20:15:45Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-in-co-occuring-major-depressive-disorder-and-borderline-personality-d 2026-05-14T20:15:45Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-in-functional-neurological-disorder-psifund 2026-05-07T16:13:03Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-in-patients-with-fibromyalgia-eeg-measured-brain-biomarkers-of-action 2026-05-07T16:12:28Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-in-the-treatment-of-cannabis-use-disorder-a-proof-of-concept-study 2026-05-07T16:14:33Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-induced-neuroplasticity-in-the-treatment-of-major-depressive-disorder 2026-05-14T20:15:46Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-mechanism-of-action-moa 2026-05-14T20:15:46Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-medicine-open-label-study-pmos-a-determination-of-the-safety-and-effi 2026-05-07T18:35:57Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-microdose-for-psychological-and-existential-distress-in-palliative-ca 2026-05-07T16:17:15Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-on-brain-mechanisms-of-motivation-in-oud 2026-05-14T20:15:46Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-rtms-for-treatment-resistant-depression 2026-05-14T20:15:46Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-therapy-for-chronic-low-back-pain 2026-05-14T20:15:46Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-therapy-for-depression-and-anxiety-in-parkinsons-disease-pdp 2026-05-14T20:15:47Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-therapy-for-depression-in-bipolar-ii-disorder-bap 2026-05-14T20:15:47Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-therapy-for-depression-in-parkinsons-disease-pdp2 2026-05-14T20:15:47Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-therapy-for-psychological-distress-in-palliative-patients-psypal 2026-05-07T16:16:20Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-therapy-in-advanced-cancer 2026-05-14T20:15:47Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-trd-feasibility-rct 2026-03-24T14:49:15Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-treatment-of-major-depressive-disorder-with-co-occurring-alcohol-use- 2026-05-14T20:15:47Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-versus-ketamine-fast-acting-antidepressant-strategies-in-treatment-re 2026-03-24T14:49:15Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-versus-ketamine-in-treatment-resistant-depression-psiket_001 2026-05-07T16:11:57Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-vs-escitalopram-for-major-depressive-disorder-comparative-mechanisms 2026-05-13T05:53:33Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-vs-ketamine-for-alcohol-use-disorder-psi-vs-ket 2026-05-14T20:15:48Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-with-intracranial-neural-sensing-pins 2026-05-14T20:15:48Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-with-psychological-support-psi-ps-for-military-veterans-and-first-res 2026-05-14T20:15:48Z monthly 0.7 https://www.moreblossom.com/trials/psilocybin-with-psychotherapy-for-improving-chronic-pain-in-cancer-patients-requ 2026-05-14T20:15:48Z monthly 0.7 https://www.moreblossom.com/trials/psiloimagine-a-psychedelic-augmented-mental-imagery-based-intervention-for-young 2026-05-07T16:16:28Z monthly 0.7 https://www.moreblossom.com/trials/psychedelic-assisted-group-program-for-first-responders 2026-05-07T16:15:24Z monthly 0.7 https://www.moreblossom.com/trials/psychedelic-healing-adjunct-therapy-harnessing-opened-malleability-phathom 2026-05-14T20:15:48Z monthly 0.7 https://www.moreblossom.com/trials/psychedelic-therapy-for-wellness-studies-retrospectively 2026-05-07T16:12:14Z monthly 0.7 https://www.moreblossom.com/trials/psychedelic-virtual-reality 2026-05-14T20:15:49Z monthly 0.7 https://www.moreblossom.com/trials/psychedelics-and-wellness-study-paws 2026-05-14T20:15:49Z monthly 0.7 https://www.moreblossom.com/trials/psychological-effects-of-methylenedioxymethamphetamine-mdma 2026-05-07T16:08:49Z monthly 0.7 https://www.moreblossom.com/trials/psychological-effects-of-methylenedioxymethamphetamine-mdma-when-administered-to 2026-05-14T20:15:49Z monthly 0.7 https://www.moreblossom.com/trials/psychological-physiological-endocrine-and-pharmacokinetic-effects-of-lsd-in-a-co 2026-05-07T16:06:00Z monthly 0.7 https://www.moreblossom.com/trials/psychopharmacology-of-psilocybin-in-cancer-patients 2026-05-14T20:15:49Z monthly 0.7 https://www.moreblossom.com/trials/qualitative-study-about-psychedelics-using-in-psychiatric-disorders-psychequali 2026-05-07T16:13:52Z monthly 0.7 https://www.moreblossom.com/trials/randomized-double-blind-active-placebo-controlled-pilot-study-of-mdma-assisted-p 2026-05-07T16:05:48Z monthly 0.7 https://www.moreblossom.com/trials/randomized-double-blind-active-placebo-controlled-study-of-ketamine-to-treat-lev 2026-05-14T20:15:49Z monthly 0.7 https://www.moreblossom.com/trials/randomized-double-blind-controlled-of-mdma-assisted-psychotherapy-in-12-subjects 2026-05-07T16:06:10Z monthly 0.7 https://www.moreblossom.com/trials/randomized-placebo-controlled-study-of-mdma-assisted-psychotherapy-in-people-wit 2026-05-07T16:04:58Z monthly 0.7 https://www.moreblossom.com/trials/rapid-antidepressant-effects-of-ketamine-in-major-depression 2026-05-14T20:15:50Z monthly 0.7 https://www.moreblossom.com/trials/reducing-adolescent-suicide-risk-safety-efficacy-and-connectome-phenotypes-of-in 2026-05-14T20:15:50Z monthly 0.7 https://www.moreblossom.com/trials/repeat-dosing-of-psilocybin-in-migraine-headache 2026-05-14T20:15:50Z monthly 0.7 https://www.moreblossom.com/trials/repeated-intranasal-esketamine-plus-almond-therapy-in-participants-with-treatmen 2026-05-07T16:12:07Z monthly 0.7 https://www.moreblossom.com/trials/repeated-intranasal-esketamine-plus-almond-therapy-in-patients-with-treatment-re 2026-05-07T16:11:48Z monthly 0.7 https://www.moreblossom.com/trials/repeated-ketamine-infusions-for-comorbid-ptsd-and-mdd-in-veterans 2026-05-14T20:15:50Z monthly 0.7 https://www.moreblossom.com/trials/repeated-neurocognitive-measurements-in-depressed 2026-05-14T20:15:50Z monthly 0.7 https://www.moreblossom.com/trials/repeated-neurocognitive-measurements-in-depressed-patients-2 2026-05-07T16:13:45Z monthly 0.7 https://www.moreblossom.com/trials/research-study-for-major-depressive-disorder-investigation-of-glutamate-medicati 2026-05-14T20:15:51Z monthly 0.7 https://www.moreblossom.com/trials/resistant-depression-ketamine-infusion-trial-evaluation 2026-05-07T16:18:53Z monthly 0.7 https://www.moreblossom.com/trials/reversal-of-battle-related-aging-robra-in-a-special-operations-forces-cohort 2026-05-14T20:15:51Z monthly 0.7 https://www.moreblossom.com/trials/reward-emotion-learning-and-ketamine-study 2026-05-07T16:10:30Z monthly 0.7 https://www.moreblossom.com/trials/role-of-dopamine-serotonin-and-5-ht2a-receptors-in-emotion-processing 2026-05-07T16:07:29Z monthly 0.7 https://www.moreblossom.com/trials/role-of-ketamine-in-treatment-resistant-major-depressive-disorder-and-its-effect 2026-05-07T16:08:53Z monthly 0.7 https://www.moreblossom.com/trials/role-of-non-specific-effects-in-the-treatment-of-depression-with-esketamine-rose 2026-05-14T20:15:51Z monthly 0.7 https://www.moreblossom.com/trials/role-of-serotonin-in-acute-and-subacute-mdma-effects 2026-05-14T20:15:51Z monthly 0.7 https://www.moreblossom.com/trials/role-of-the-serotonin-2a-receptor-in-psilocybin-induced-altered-states-of-consci 2026-05-07T16:16:27Z monthly 0.7 https://www.moreblossom.com/trials/role-of-the-serotonin-5-ht2a-receptor-in-lsd-induced-altered-states-of-conscious 2026-05-07T16:07:52Z monthly 0.7 https://www.moreblossom.com/trials/role-of-the-serotonin-5-ht2a-receptor-in-mescaline-induced-altered-states-of-con 2026-05-07T16:10:29Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-efficacy-of-ketamine-intravenous-infusions-in-the-treatment-of-fibrom 2026-05-07T16:16:55Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-efficacy-of-low-dose-mm-120-for-adhd-proof-of-concept-trial 2026-05-07T16:11:22Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-efficacy-of-psilocybin-assisted-psychotherapy-for-demoralization-synd 2026-05-07T16:16:39Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-efficacy-of-psilocybin-assisted-psychotherapy-for-generalised-anxiety 2026-05-07T18:35:28Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-efficacy-of-psilocybin-for-body-dysmorphic-disorder 2026-05-14T20:15:51Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-pharmacokinetics-of-gh002-in-healthy-volunteers 2026-05-07T16:13:09Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-psychological-effects-of-psilocybin-and-d-serine-formulation-in-healt 2026-05-07T16:17:18Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-tolerability-of-dmt-in-healthy-adults 2026-05-07T16:13:31Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-tolerability-of-psilocybin-assisted-physiotherapy-in-healthy-voluntee 2026-05-07T18:35:24Z monthly 0.7 https://www.moreblossom.com/trials/safety-and-tolerability-of-psilocybin-in-post-traumatic-stress-disorder 2026-05-07T16:12:33Z monthly 0.7 https://www.moreblossom.com/trials/safety-biomarker-study-of-rl-007-in-subjects-with-schizophrenia 2026-05-14T20:15:52Z monthly 0.7 https://www.moreblossom.com/trials/safety-blood-levels-and-effects-of-nn-dimethyltryptamine-dmt-spl026-in-healthy-p 2026-05-07T16:18:50Z monthly 0.7 https://www.moreblossom.com/trials/safety-for-home-administration-of-microdose-psilocybin-use 2026-05-14T20:15:52Z monthly 0.7 https://www.moreblossom.com/trials/safety-of-gh001-in-healthy-volunteers 2026-05-07T16:09:56Z monthly 0.7 https://www.moreblossom.com/trials/safety-profile-of-psilocybin-for-cocaine-use-disorder 2026-05-14T20:15:52Z monthly 0.7 https://www.moreblossom.com/trials/safety-tolerability-analgesic-effect-and-feasibility-of-intranasal-ct001-in-pedi 2026-05-07T16:14:56Z monthly 0.7 https://www.moreblossom.com/trials/safety-tolerability-and-antidepressant-effects-of-dmt-in-patients-with-depresio 2026-05-07T16:14:10Z monthly 0.7 https://www.moreblossom.com/trials/safety-tolerability-and-efficacy-of-sublingual-microdoses-of-5-meo-dmt-for-depre 2026-05-07T16:16:37Z monthly 0.7 https://www.moreblossom.com/trials/safety-tolerability-and-feasibility-of-psilocybin-facilitated-treatment-for-meth 2026-05-13T06:26:08Z monthly 0.7 https://www.moreblossom.com/trials/safety-tolerability-and-preliminary-efficacy-of-psilocybin-oral-solution-in-adul 2026-05-07T16:17:04Z monthly 0.7 https://www.moreblossom.com/trials/safety-tolerability-pharmacokinetics-pharmacodynamics-and-exploratory-efficacy-o 2026-05-07T16:18:42Z monthly 0.7 https://www.moreblossom.com/trials/safety-tolerability-pharmacokinetics-pk-pharmacodynamics-pd-and-effects-of-intra 2026-05-07T16:18:49Z monthly 0.7 https://www.moreblossom.com/trials/salivary-oxytocin-as-a-biomarker-in-psychedelic-assisted-psychotherapy-pap_oxt 2026-05-07T16:15:37Z monthly 0.7 https://www.moreblossom.com/trials/sequential-therapy-for-the-treatment-of-severe-bipolar-depression 2026-05-14T20:15:52Z monthly 0.7 https://www.moreblossom.com/trials/single-and-repeat-doses-of-dmt-in-healthy-subjects 2026-05-07T16:12:32Z monthly 0.7 https://www.moreblossom.com/trials/single-ascending-dose-study-with-bpl-003-in-healthy-subjects 2026-05-07T16:11:52Z monthly 0.7 https://www.moreblossom.com/trials/single-dose-ketamine-for-the-reduction-of-pain-and-depression-in-the-emergency-d 2026-05-07T16:08:04Z monthly 0.7 https://www.moreblossom.com/trials/single-dose-ketamine-treatment-to-improve-depression-in-mild-cognitive-impairmen 2026-05-14T20:15:52Z monthly 0.7 https://www.moreblossom.com/trials/social-anxiety-mdma-assisted-therapy-investigation-samati 2026-05-14T20:15:53Z monthly 0.7 https://www.moreblossom.com/trials/spl026-dmt-fumarate-in-healthy-subjects-and-mdd-patients 2026-05-07T16:10:03Z monthly 0.7 https://www.moreblossom.com/trials/spl026-with-or-without-ssris-in-participants-with-mdd 2026-05-07T16:12:29Z monthly 0.7 https://www.moreblossom.com/trials/spreading-depolarization-and-ketamine-suppression 2026-05-14T20:15:53Z monthly 0.7 https://www.moreblossom.com/trials/standardized-natural-psilocybin-assisted-psychotherapy-for-tapering-of-opioid-me 2026-05-07T16:12:40Z monthly 0.7 https://www.moreblossom.com/trials/stanford-reward-circuits-of-the-brain-study-mdma 2026-05-14T20:15:53Z monthly 0.7 https://www.moreblossom.com/trials/state-funded-trial-assessing-recovery-and-long-term-impact-of-guided-psilocybin- 2026-05-14T20:15:53Z monthly 0.7 https://www.moreblossom.com/trials/stress-experience-following-psilocybin-sep-1 2026-05-07T16:16:17Z monthly 0.7 https://www.moreblossom.com/trials/study-comparing-three-doses-of-mdma-along-with-psychotherapy-in-veterans-with-po 2026-05-14T20:15:53Z monthly 0.7 https://www.moreblossom.com/trials/study-comparing-two-versus-three-active-mdma-assisted-sessions-in-u-s-military-v 2026-05-14T20:15:54Z monthly 0.7 https://www.moreblossom.com/trials/study-of-34-methylenedioxymethamphetamine-assisted-psychotherapy-in-people-with- 2026-05-07T16:04:57Z monthly 0.7 https://www.moreblossom.com/trials/study-of-depression-ketamine-brain-function 2026-05-07T16:05:17Z monthly 0.7 https://www.moreblossom.com/trials/study-of-feasibility-and-safety-of-mdma-assisted-group-therapy-for-the-treatment 2026-05-07T16:11:17Z monthly 0.7 https://www.moreblossom.com/trials/study-of-harmine-in-healthy-subjects 2026-05-14T20:15:54Z monthly 0.7 https://www.moreblossom.com/trials/study-of-iv-ketamine-for-emergency-department-treatment-of-adolescent-suicidal-2 2026-05-07T16:12:14Z monthly 0.7 https://www.moreblossom.com/trials/study-of-iv-ketamine-for-emergency-department-treatment-of-adolescent-suicidal-i 2026-05-07T16:14:57Z monthly 0.7 https://www.moreblossom.com/trials/study-of-ketamine-as-an-antidepressant-in-major-depressive-disorder 2026-05-07T16:05:42Z monthly 0.7 https://www.moreblossom.com/trials/study-of-ketamine-for-depression-in-cancer-patients-receiving-palliative-care 2026-05-07T16:08:01Z monthly 0.7 https://www.moreblossom.com/trials/study-of-ketamine-for-youth-depression 2026-05-07T18:36:59Z monthly 0.7 https://www.moreblossom.com/trials/study-of-oral-ketamine-versus-placebo-for-treating-depression-in-patients-underg 2026-05-14T20:15:54Z monthly 0.7 https://www.moreblossom.com/trials/study-of-psilocybin-enhanced-group-psychotherapy-in-patients-with-cancer 2026-05-14T20:15:54Z monthly 0.7 https://www.moreblossom.com/trials/study-of-psilocybin-for-anorexia-in-young-adults-spanya 2026-05-14T20:15:54Z monthly 0.7 https://www.moreblossom.com/trials/study-of-safety-and-effects-of-mdma-assisted-psychotherapy-for-treatment-of-ptsd 2026-05-07T16:08:06Z monthly 0.7 https://www.moreblossom.com/trials/study-of-the-effects-of-mdma-ecstasy-on-water-regulation-sleep-and-cognition 2026-05-14T20:15:55Z monthly 0.7 https://www.moreblossom.com/trials/study-of-the-neural-circuits-underlying-the-negative-emotional-bias-of-depressiv 2026-05-07T16:15:51Z monthly 0.7 https://www.moreblossom.com/trials/study-of-the-safety-and-feasibility-of-psilocybin-in-adults-with-methamphetamine 2026-05-14T20:15:55Z monthly 0.7 https://www.moreblossom.com/trials/study-of-the-safety-tolerability-electrophysiological-effects-and-efficacy-of-dm 2026-05-14T20:15:55Z monthly 0.7 https://www.moreblossom.com/trials/study-to-assess-the-effects-of-intranasal-ketamine-along-with-rtms-for-patients- 2026-05-07T16:09:21Z monthly 0.7 https://www.moreblossom.com/trials/study-to-evaluate-the-efficacy-and-safety-of-3-fixed-doses-of-intranasal-esketam 2026-05-14T20:15:55Z monthly 0.7 https://www.moreblossom.com/trials/study-where-pharmaco-magnetic-resonance-imaging-mri-effects-of-azd6765-will-be-c 2026-05-07T16:05:14Z monthly 0.7 https://www.moreblossom.com/trials/studying-the-antidepressant-effects-of-intravenous-ketamine-in-patients-with-maj 2026-05-07T18:36:32Z monthly 0.7 https://www.moreblossom.com/trials/subacute-profiling-of-2c-b-versus-psilocybin 2026-04-27T13:47:13Z monthly 0.7 https://www.moreblossom.com/trials/subanesthetic-iv-bolus-ketamine-in-the-treatment-of-acute-depression 2026-05-14T20:15:55Z monthly 0.7 https://www.moreblossom.com/trials/subcutaneous-ketamine-infusion-in-palliative-care-patients-with-advanced-life-li 2026-05-07T19:02:05Z monthly 0.7 https://www.moreblossom.com/trials/sustained-ketamine-effectiveness-for-suicidal-ideation-skesi 2026-05-07T16:16:29Z monthly 0.7 https://www.moreblossom.com/trials/sustaining-remission-from-ptsd-using-tuned-vibroacoustic-stimulation-tvs-followi 2026-05-14T20:15:56Z monthly 0.7 https://www.moreblossom.com/trials/swinburne-three-dose-psilocybin-assisted-psychotherapy-3pap-a-clinical-trial-of- 2026-05-07T18:37:29Z monthly 0.7 https://www.moreblossom.com/trials/synaptic-imaging-and-network-activity-in-treatment-resistant-depression-signatur 2026-05-07T16:13:26Z monthly 0.7 https://www.moreblossom.com/trials/testing-the-effectiveness-of-cognitive-training-among-depressed-patients-receivi 2026-05-14T20:15:56Z monthly 0.7 https://www.moreblossom.com/trials/thc-and-ketamine-effects-in-humans-relation-to-neural-oscillations-and-psychosis 2026-05-14T20:15:56Z monthly 0.7 https://www.moreblossom.com/trials/the-acute-effects-of-psilocybin-on-cognition-memory-and-brain-function 2026-05-14T20:15:56Z monthly 0.7 https://www.moreblossom.com/trials/the-anesthetic-ketamine-as-treatment-for-patients-with-severe-acute-brain-injury 2026-05-07T16:11:05Z monthly 0.7 https://www.moreblossom.com/trials/the-bio-k-study-a-single-arm-open-label-biomarker-development-clinical-trial-of- 2026-05-14T20:15:56Z monthly 0.7 https://www.moreblossom.com/trials/the-check-trial-a-comparison-of-headache-treatment-in-the-emergency-department-c 2026-05-14T20:15:57Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-a-four-week-intensified-pharmacological-treatment-for-major-depres 2026-05-07T16:13:41Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-esketamine-on-sleep-disturbance 2026-05-07T16:15:04Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-intranasal-ketamine-on-suicidality-in-severely-depressed-and-suici 2026-03-24T14:49:52Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-ketamine-on-aesthetics-and-role-for-antidepressant-effects 2026-05-07T16:11:45Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-ketamine-on-mechanises-underlying-suicidal-ideation-and-drug-resis 2026-05-07T16:06:16Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-lsd-on-neural-synchrony-prosocial-behavior-and-relationship-qualit 2026-05-07T16:12:53Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-minocycline-on-relapse-after-successful-intravenous-ketamine-minoc 2026-05-07T16:05:54Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-outpatient-ketamine-infusion-on-chronic-neuropathic-pain-and-ptsd 2026-05-14T20:15:57Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-psilocybin-on-mdd-symptom-severity-and-synaptic-density 2026-05-07T16:09:54Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-s-ketamine-for-patients-undergoing-electroconvulsive-therapy-ect 2026-05-07T16:09:25Z monthly 0.7 https://www.moreblossom.com/trials/the-effect-of-transcranial-magnetic-stimulation-and-oral-ketamine-combination-tr 2026-05-07T19:02:58Z monthly 0.7 https://www.moreblossom.com/trials/the-effectiveness-and-safety-of-esketamine-in-modified-electroconvulsive-therapy 2026-05-07T16:10:19Z monthly 0.7 https://www.moreblossom.com/trials/the-effectiveness-of-continuous-ketamine-infusion-kontinue 2026-05-07T16:14:16Z monthly 0.7 https://www.moreblossom.com/trials/the-effects-of-ketamine-and-methadone-on-postoperative-pain-for-laminectomy 2026-05-14T20:15:57Z monthly 0.7 https://www.moreblossom.com/trials/the-effects-of-low-dose-ketamine-on-cardiovascular-function 2026-05-14T20:15:57Z monthly 0.7 https://www.moreblossom.com/trials/the-effects-of-mdma-on-prefrontal-and-amygdala-activation-in-ptsd 2026-05-14T20:15:57Z monthly 0.7 https://www.moreblossom.com/trials/the-effects-of-psilocybin-facilitated-experience-on-the-psychology-and-effective 2026-05-14T20:15:58Z monthly 0.7 https://www.moreblossom.com/trials/the-effects-of-psilocybin-on-self-focus-and-self-related-processing-in-major-dep 2026-05-14T20:15:58Z monthly 0.7 https://www.moreblossom.com/trials/the-effects-of-psilocybin-on-self-focus-and-self-related-processing-in-treatment 2026-05-14T20:15:58Z monthly 0.7 https://www.moreblossom.com/trials/the-effects-of-sedatives-on-tobacco-use-disorder-version-2-sed-tud2 2026-05-14T20:15:58Z monthly 0.7 https://www.moreblossom.com/trials/the-effects-of-three-small-morning-and-evening-doses-of-lsd-on-mood-biological-a 2026-03-17T13:57:02Z monthly 0.7 https://www.moreblossom.com/trials/the-efficacy-of-ibogaine-in-the-treatment-of-addiction-an-open-label-single-fixe 2026-03-17T13:57:03Z monthly 0.7 https://www.moreblossom.com/trials/the-efficacy-of-psilocybin-assisted-psychotherapy-pap-for-treatment-resistant-ob 2026-05-07T18:35:56Z monthly 0.7 https://www.moreblossom.com/trials/the-impact-of-ampa-receptor-blockade-on-ketamines-anti-suicidal-effects 2026-05-14T20:15:59Z monthly 0.7 https://www.moreblossom.com/trials/the-impact-of-ketamine-on-the-reward-circuitry-of-suicidal-patients 2026-05-14T20:15:59Z monthly 0.7 https://www.moreblossom.com/trials/the-impact-of-psilocybin-on-pain-in-fibromyalgia-patients-and-healthy-volunteers 2026-03-24T14:49:59Z monthly 0.7 https://www.moreblossom.com/trials/the-impact-of-psilocybin-on-pain-in-fibromyalgia-patients-psilofm 2026-05-07T16:14:59Z monthly 0.7 https://www.moreblossom.com/trials/the-incidence-of-hyponatremia-in-people-using-mdma 2025-11-08T00:10:56Z monthly 0.7 https://www.moreblossom.com/trials/the-kite-trial-examining-the-effectiveness-of-ketamine-for-adults-with-bipolar-d 2026-05-07T19:04:57Z monthly 0.7 https://www.moreblossom.com/trials/the-neurobiological-effect-of-5-ht2ar-modulation 2026-05-07T16:07:49Z monthly 0.7 https://www.moreblossom.com/trials/the-next-study 2026-04-06T18:45:25Z monthly 0.7 https://www.moreblossom.com/trials/the-observe-protocol 2026-05-14T20:15:59Z monthly 0.7 https://www.moreblossom.com/trials/the-perinatal-synergistic-multi-component-intervention-to-alleviate-depressive-s 2026-05-14T20:15:59Z monthly 0.7 https://www.moreblossom.com/trials/the-potential-therapeutic-effects-of-psychedelic-n-n-dimethyltryptamine-dmt-on-a 2026-05-14T20:15:59Z monthly 0.7 https://www.moreblossom.com/trials/the-recap2-study-midazolam-and-psilocybin 2026-05-14T20:16:00Z monthly 0.7 https://www.moreblossom.com/trials/the-role-of-5-ht2-and-5-ht1a-receptors-in-34-methylenedioxymethamphetamine-mdma- 2026-04-27T13:47:17Z monthly 0.7 https://www.moreblossom.com/trials/the-role-of-5-ht2a-receptor-in-the-perception-of-self-and-personal-meaning-in-he 2026-05-07T16:06:50Z monthly 0.7 https://www.moreblossom.com/trials/the-role-of-cyp2d6-in-the-pharmacokinetics-of-ibogaine-in-healthy-volunteers 2026-05-07T18:39:56Z monthly 0.7 https://www.moreblossom.com/trials/the-role-of-hnks-in-the-antidepressant-effect-of-ketamine 2026-05-14T20:16:00Z monthly 0.7 https://www.moreblossom.com/trials/the-role-of-mtor-mammalian-target-of-rapamycin-signaling-pathway-in-the-antidepr 2026-03-24T14:50:03Z monthly 0.7 https://www.moreblossom.com/trials/the-role-of-personal-experience-for-the-therapeutic-attitude-in-the-context-of-s 2026-05-07T16:12:35Z monthly 0.7 https://www.moreblossom.com/trials/the-role-of-the-5-ht2a-receptor-in-mdma-induced-effects-on-social-cognition-and- 2026-04-27T13:47:22Z monthly 0.7 https://www.moreblossom.com/trials/the-safety-and-efficacy-of-psilocybin-as-an-adjunctive-therapy-in-participants-w 2026-05-14T20:16:00Z monthly 0.7 https://www.moreblossom.com/trials/the-safety-and-efficacy-of-psilocybin-in-cancer-patients-with-major-depressive-d 2026-05-14T20:16:00Z monthly 0.7 https://www.moreblossom.com/trials/the-safety-and-efficacy-of-psilocybin-in-participants-with-treatment-resistant-d 2026-05-14T20:16:00Z monthly 0.7 https://www.moreblossom.com/trials/the-safety-and-efficacy-of-psilocybin-in-participants-with-type-2-bipolar-disord 2026-05-14T20:16:01Z monthly 0.7 https://www.moreblossom.com/trials/the-safety-and-efficacy-of-psilocybin-in-patients-with-treatment-resistant-depre 2026-05-14T20:16:01Z monthly 0.7 https://www.moreblossom.com/trials/the-safety-and-tolerability-of-comp360-in-participants-with-post-traumatic-stres 2026-05-14T20:16:01Z monthly 0.7 https://www.moreblossom.com/trials/the-use-of-ketamine-as-an-anaesthetic-during-electroconvulsive-therapy 2026-05-07T16:05:28Z monthly 0.7 https://www.moreblossom.com/trials/the-uthealth-ketamine-project 2026-05-14T20:16:02Z monthly 0.7 https://www.moreblossom.com/trials/tolerability-of-mdma-in-schizophrenia-tms 2026-05-14T20:16:02Z monthly 0.7 https://www.moreblossom.com/trials/tolerance-and-potential-synergistic-effect-of-the-combination-of-intranasal-eske 2026-05-07T16:12:26Z monthly 0.7 https://www.moreblossom.com/trials/toward-embodied-healing-feasibility-of-a-psilocybin-assisted-psychotherapy-for-p 2026-05-07T18:35:49Z monthly 0.7 https://www.moreblossom.com/trials/treatment-of-persistent-post-concussive-symptoms-with-psilocybin-assisted-therap 2026-05-07T16:15:47Z monthly 0.7 https://www.moreblossom.com/trials/treatment-of-suicidal-ideation-in-the-emergency-department-using-nitrous-oxide-p 2026-05-07T16:15:16Z monthly 0.7 https://www.moreblossom.com/trials/treatment-of-suicidal-ideation-with-intravenous-ketamine-infusion 2026-05-14T20:16:02Z monthly 0.7 https://www.moreblossom.com/trials/treatment-resistant-depression-intervention-with-psilocybin-assisted-psychothera 2026-05-07T18:43:26Z monthly 0.7 https://www.moreblossom.com/trials/treatment-resistant-depression-pilot 2026-05-14T20:16:02Z monthly 0.7 https://www.moreblossom.com/trials/treatment-study-of-bipolar-depression 2026-05-14T20:16:03Z monthly 0.7 https://www.moreblossom.com/trials/treatment-with-psilocybin-for-chronic-neuropathic-pain-and-depression-transcend- 2026-05-07T16:15:33Z monthly 0.7 https://www.moreblossom.com/trials/trial-of-ketamine-and-lithium-therapy-in-bipolar-depression 2026-05-07T16:05:51Z monthly 0.7 https://www.moreblossom.com/trials/trial-of-the-rapid-antisuicidal-effects-of-intranasal-ketamine-in-comorbid-depre 2026-05-14T20:16:03Z monthly 0.7 https://www.moreblossom.com/trials/trifecta-research-study 2026-05-14T20:16:03Z monthly 0.7 https://www.moreblossom.com/trials/trips-treatment-to-improve-depression-and-or-anxiety-using-psilocybin-assisted-p 2026-05-14T20:16:03Z monthly 0.7 https://www.moreblossom.com/trials/understanding-and-treating-suicidal-ideation-with-ketamine 2026-05-07T16:16:48Z monthly 0.7 https://www.moreblossom.com/trials/understanding-neuroplasticity-induced-by-tryptamines-unity-the-effects-of-dimeth 2026-05-07T16:18:43Z monthly 0.7 https://www.moreblossom.com/trials/university-of-iowa-interventional-psychiatry-service-patient-registry 2026-05-14T20:16:03Z monthly 0.7 https://www.moreblossom.com/trials/use-of-ketamine-to-enhance-electroconvulsive-therapy-ect-in-depression 2026-05-14T20:16:04Z monthly 0.7 https://www.moreblossom.com/trials/use-of-transmucosal-ketamine-in-post-stroke-depression 2026-05-14T20:16:04Z monthly 0.7 https://www.moreblossom.com/trials/using-a-low-dose-of-ketamine-vs-active-placebo-in-treating-severe-depression-and 2026-05-07T16:08:16Z monthly 0.7 https://www.moreblossom.com/trials/using-virtual-reality-to-control-the-audio-visual-inputs-during-ketamine-esketam 2026-05-14T20:16:04Z monthly 0.7 https://www.moreblossom.com/trials/uw-psilocybin-pharmacokinetics-study 2026-05-14T20:16:04Z monthly 0.7 https://www.moreblossom.com/trials/va-aripiprazole-vs-esketamine-for-treatment-resistant-depression-vast-d-ii 2026-05-14T20:16:04Z monthly 0.7 https://www.moreblossom.com/trials/veterans-perceptions-of-ketamine-assisted-psychotherapy-for-depression-and-end-o 2026-05-14T20:16:05Z monthly 0.7 https://www.moreblossom.com/trials/visual-surround-suppression-and-perceptual-expectation-under-psilocybin 2026-05-14T20:16:05Z monthly 0.7 https://www.moreblossom.com/trials/wellcome-leap-psilocybin-for-oud 2026-05-14T20:16:05Z monthly 0.7